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PREFACE 
 
The Ouroboros, a serpent consuming its own tail, is a mythological icon that has 
existed in various cultures throughout history.  For many it symbolizes the endless, 
cyclical nature of the world.  Every new thing comes from an old thing.  To create, 
something must first be destroyed.  I find that this theme applies quite well to my time 
spent as a graduate student. 
My first project in this lab encountered unexpected difficulties.  After having 
worked on this for almost an entire school year, I abandoned this project and switched 
completely to working on my eventual thesis project.  The demise of my first project, 
though unfortunate, led to the start of my dissertation work. 
The process of regulated cell death itself embodies the theme represented by 
Ouroboros.  The cell corpses or debris do not simply vanish after the cells die.  Its 
components will be broken down somehow and reused by the organism, which at some 
point will likely generate new cells.  Thus, the death of old cells will lead to the birth of 
new ones. 
Finally, my experience working on this project and writing this thesis has been a 
constant process of death and rebirth, whether it is ideas, experiments, or future 
directions.  One of the greatest things about science is that there is always new 
knowledge to discover, even if it is not new to you, and the same knowledge can prompt 
different ideas or responses from different people.  If nothing else, I hope that readers of 
this thesis will gain a better appreciation for the never-ending cycle of ideas, and how to 
test them, which makes this endeavor seem so futile and worthwhile at the same time. 
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ABSTRACT 
 
Programmed cell death is often thought of as a developmental process that is 
genetically hardwired to occur in the organism in a spatially and temporally specific 
manner.  However, many forms of regulated cell death occur in response to 
pathological injury or environmental stress.  Cell death in response to injury, in 
particular genotoxic stress, is well documented, but the pathways by which damage is 
translated to cell death have remained largely elusive.  Furthermore, many cell death 
pathways function independently of the well-known process of apoptosis.  These 
alternative regulated cell death pathways are likely controlled by novel molecular 
mechanisms. 
While examining mutations that cause loss of neural stem cells (neuroblasts) 
in Drosophila larval brains, we discovered a novel mechanism elicited by 
Cdc20/Fizzy (Fzy) that maintains neuroblasts by promoting their survival.  We 
identified two fzy loss-of-function mutations that specifically led to neuroblast loss 
without perturbing the proliferation of other cell types.  Consistently, mutant Fzy or 
Cdc20 carrying the analogous mutation can substitute for wild-type Cdc20 and 
restore cell cycle progression in fzy mutant brains.  Furthermore, these fzy mutant 
neuroblasts do not display characteristics indicative of known cell death pathways, 
such as apoptosis, autophagic cell death, or mitotic catastrophe.  Instead, 
morphological and functional analyses strongly suggest that Fzy maintains 
neuroblasts by suppressing necrotic cell death.  Inactivating the function of apoptosis 
inducing factor (aif) or c-Jun N-terminal kinase (JNK) signaling prolonged the 
survival of fzy mutant neuroblasts, while ectopically activating JNK signaling triggers 
premature necrotic cell death in neuroblasts.  These results suggest that JNK signaling 
and aif play a role in neuroblast necrosis. 
xii 
 
Loss of telomere capping proteins or chaperonin proteins required for spindle 
formation caused a similar necrosis phenotype as the fzy mutant neuroblasts.  These 
mutations also caused DNA damage or cell cycle disruption.  Furthermore, over-
expression of the cell cycle checkpoint protein p53 also caused neuroblast necrosis.  
Importantly, Fzy expression was decreased in each of these mutations.  We propose a 
novel necrotic cell death mechanism triggered by catastrophic damage of neuroblasts 
which leads to up-regulation of p53.  Increased p53 activity results in loss of Fzy 
expression and Fzy-dependent necrotic cell death.  
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CHAPTER 1 
INTRODUCTION 
 
 
The ability of an organism to control the number of cells in its body during 
development and disease is absolutely critical to ensure proper growth, tissue 
homeostasis, body patterning, and survival of cellular insults from various sources.  Stem 
cells play an important role in these processes because of their abilities to self-renew and 
differentiation, allowing them to produce new functional cells as well as replace old cells 
that are lost.  Cell death complements the actions of stem cells by removing cells from 
the organism.  Cell death can function to remove either differentiated cells or the stem 
cells themselves.  An improper shift in the balance between the proliferation of stem cells 
and the death of stem cells or their progeny could lead to developmental defects or 
disease.  The importance of stem cell death regulation is amplified compared to other cell 
types because the loss of a stem cell is typically irreversible whereas a lost differentiated 
cell can be replaced by a stem or progenitor cell.  However, very little is known about the 
regulation of programmed cell death in stem cells. 
Genetically regulated cell death can occur as a result of a developmental program 
or in response to injury or other environmental stimuli.  There are situations where 
organisms find it advantageous to kill cells even if they are normally very important, such 
as when a stem cell has suffered irreparable DNA damage.  The removal of these cells 
prevents the production of progeny with genetic alterations, which can predispose the 
cells to cancer.  The most common cell death program, apoptosis, is thought to contribute 
to the majority of primary regulated cell death in response in injury.  However, there are 
many situations in which apoptosis or the primary cell death program is blocked.  Thus, 
the existence of secondary mechanisms, such as necrotic cell death, may be critical to 
prevent undesired consequences.  While much work on cell death has focused on
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mechanisms that trigger primary cell death, our understanding of secondary mechanisms 
of cell death is far less complete. 
The Drosophila larval neuroblast is a well-established model for studying 
asymmetric cell division and stem cell biology.  However, like all other stem cell models, 
very little is known about how neuroblasts regulate programmed cell death, particularly 
in response to irreversible damage.  The goal of this introduction is to briefly review what 
is known about programmed cell death while giving special attention to the concept of 
primary versus secondary cell death mechanisms and the roles of apoptosis and necrosis.  
The current literature on programmed cell death in neuroblasts will also be reviewed. 
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Programmed Cell Death 
 
 The first published experiments on programmed cell death were performed in 
another insect: the silk moth pupa.  In 1965, Lockshin and Williams demonstrated in a 
series of papers that in the first few days of adulthood, the silk moth intersegmental 
muscles undergo a programmed cytolysis1,2.  This cytolysis consistently occurred a few 
days after the increase of circulating hormone and muscle protease levels.  Furthermore, 
this process depended on the cessation of electric impulses from the nervous system.  
These studies represented a landmark in the nascent field of cell death.  While the 
principle of a pre-programmed mechanism triggering developmental cell death may have 
been proposed before, this was the first demonstration of a mechanism correlated to cell 
death.  
Several years later, Kerr, Wyllie, and Currie set the standard for detecting and 
distinguishing the different modes of cell death for decades3.  Transmission electron 
microscopy was used to identify a distinct morphological pattern associated with each 
cell death pathway.  Unique features of the newly coined “apoptosis” included nuclear 
condensation and fragmentation, shedding of membrane bound cell fragments and uptake 
of these fragments by phagocytic cells.  Ultrastuctural evidence of apoptosis was found in 
both developmental as well as pathological contexts, in tissues ranging from embryonic 
mesenchyme to injured liver.   
While very little molecular evidence was presented, these observations 
demonstrated a method for differentiating apoptosis from necrosis, which was defined as 
the breakdown and death of cells in an unregulated manner.  Coincidentally, apoptosis 
was originally called shrinkage necrosis in reference to its morphological features.  Even 
today, the term necrosis is sometimes used as an all-encompassing description for cell 
death that cannot be clearly delineated as apoptosis. 
 In the 1980s, Bob Horvitz and colleagues published arguably the most seminal 
studies to date on programmed cell death.  They discovered the genes responsible for 
developmental apoptosis in the roundworm Caenorhabditis elegans4,5.  In 2002, Sydney 
Brenner, Bob Horvitz, and John Sulston were awarded the Nobel Prize in medicine for 
their contributions to this discovery.    
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Apoptosis 
 
 Apoptosis has been found to be a critical and widespread mechanism for 
elimination of unneeded or unwanted cells during development and disease.  It is 
generally thought of as a quiet cell ‘suicide’, as opposed to necrosis which is typically 
associated with the release of cellular contents and inflammation.  All 131 somatic cells 
that are programmed to die in a developing C. elegans can survive if apoptosis is 
blocked6.  Drosophila requires apoptosis for leg formation and proper morphogenesis of 
the head and male genitalia7–9.  Mammalian digits would not form properly if apoptosis 
did not remove the interdigital webs present early in development10.  During viral 
infections, mammalian immune systems are capable of detecting and eliminating infected 
cells by apoptosis to protect the host.  Many cancers have been found to contain 
mutations that inhibit apoptosis, allowing the disease to escape a potential protective 
mechanism.  In contrast, much of the damage caused by ischemia/reperfusion injuries of 
cardiomyocytes and neural tissues is due to cell death.  Finally, some neurodegenerative 
diseases also lead to inappropriate apoptosis. 
Kerr and colleagues were able to distinguish apoptosis from necrosis by 
morphology3.  Apoptotic cells usually exhibit rounding up, nuclear condensation, overall 
cell shrinkage, shedding of apoptotic bodies containing intact plasma membrane and 
organelles, and engulfment by phagocytes.  By contrast, necrotic cell death is typically 
associated with nuclear fragmentation, cellular swelling, rupture of the plasma 
membrane, and release of cellular contents into the surrounding environment which often 
triggers and inflammatory response11.  
 The core machinery of apoptosis has been particularly well studied and is 
conserved among model organisms (Fig 1.1).  While the known complexity varies 
between the different organisms, they all require the activation of caspases, a family of 
cysteine proteases.  Caspases typically exist in an inactive form but cleavage at specific 
aspartic residues results in active subunits which heterotetramerize into active protease 
complexes12.  The first caspases to be activated in the cascade are apical or initiator 
caspases and have quite specific targets.  The last caspases to be activated, called 
executioner caspases, are more promiscuous and are largely responsible for the well 
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documented morphological changes associated with apoptosis13.  Execution of cell death 
is the most famous function of caspases.  However, not all caspases participate in 
apoptosis14,15. 
Apoptosis can be broadly characterized into two categories based on the source of 
the stimulus: intrinsic versus extrinsic (Fig 1.2).  The extrinsic pathway begins with the 
binding of a death receptor on the cell surface to its ligand.  The activation of the receptor 
then leads to activation of a pro-death caspase, Caspase-8.  Caspase-8 is able to activate 
the downstream executioner caspase as well as trigger mitochondrial release of 
Cytochrome c.  The mitochondria play a large role in the intrinsic apoptosis pathway and 
are also activated in some but not all instances of extrinsic death receptor signaling13.  
The intrinsic pathway begins with a cellular insult or stress resulting in a loss of 
mitochondrial membrane potential.  The defective mitochondria are then triggered to 
release Cytochrome c, which subsequently binds to the adaptor subunit Apaf-1 to form an 
activated caspase complex which begins the caspase cascade.   
All caspase-mediated cell deaths require the activation of downstream executioner 
or effector caspases (DrICE/Dcp-1 or Caspase-3/7) by upstream initiator caspases (CED-
3, Dronc, or Caspase-9) (Fig 1.1).  Furthermore, they all share the requirement for an 
adaptor subunit (CED-4, Ark, Apaf-1) to assemble the upstream caspase complexes.  
Drosophila and mammals also express inhibitors of apoptosis (DIAP or XIAP) which 
help regulate caspase activity in the absence of cell death activation.  Upstream death 
signals which antagonize IAPs exist in both flies and mammals.  The three IAP 
suppressing genes reaper, hid, and grim are thought to control almost all apoptosis in 
Drosophila16.  Regulation of these factors acts as a nexus for integrating multiple 
signaling pathways to the core cell death machinery17.  Analogous genes have been found 
in mammals as well18,19. 
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Necrosis 
 
Recent advances in cell death research have revealed a startling variety of 
programmed cell death pathways as well as complications in their regulation and 
crosstalk.  These new findings warranted the formation of the Nomenclature Committee 
on Cell Death who have proposed formal definitions of cell death modalities20.  
Programmed necrosis is particularly intriguing because of the history of necrosis as an 
unregulated cell death pathway.  
 Necrosis was once defined as any cell death that is not regulated or genetically 
programmed.  Necrosis became synonymous with uncontrolled cell death in response to 
injury or disease.  Nonetheless, necrosis has always been associated with several key 
morphological features: swelling of the cells, breakdown of the nucleus and plasma 
membrane rupture.  More recent additions to the signature of necrosis include increased 
cytoplasmic calcium, acidification of the cytoplasm, large scale DNA fragmentation, and 
increased reactive oxygen species. 
In the late 1980s and 1990s, accumulating evidence suggested that some signaling 
molecules or cellular insults could trigger either apoptotic or necrotic cell death21–23.  
Numerous examples of regulated necrosis exist in the invertebrate literature, but the best 
characterized mechanism is mammalian receptor-interacting protein (RIP)-dependent 
necrosis or necroptosis11,24.  The key feature of this mechanism is the requirement for 
activation of RIP1 and RIP3 kinases.  Multiple upstream activators of RIP kinases have 
been found, including death signals such as TNF, Fas, genotoxic stress, and certain 
infections25–27.  Once RIP1 is activated, it can signal in one of three fashions.  
Ubiquitination of RIP1 by cellular inhibitor of apoptosis 1 (cIAP1) leads to activation of 
nuclear-factor-κB (NF-κB) signaling, a pro-survival pathway.  Alternately, RIP1 can also 
function in a complex with Caspase-8 and participate in the death receptor-dependent 
apoptosis pathway.  Finally, in the absence of Caspase-8 activity or in the presence of 
certain stressors such as genotoxic damage or viral infections, RIP1 may associate with 
RIP3 as part of the ‘necrosome’ which ultimately triggers effectors of necrosis. 
 The developing fly oocyte is one of the few Drosophila tissues in which 
programmed necrosis has been established28.  A mature fly ovary consists of multiple 
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ovarioles, each ovariole shaped like a chain of beads of increasing size.  Each bead is a 
developing egg chamber comprising 16 germline cells surrounded by up to 1000 somatic 
follicle cells.  Eventually, one of the germ cells of each egg chamber is specified to 
become the oocyte.  The remaining germ cells become nurse cell which provide nutrients, 
organelles, and mRNA to the oocyte.  Necrosis occurs in late stage fly oocytes, when 
nurse cells are programmed transfer their cytoplasmic contents to the oocyte and then die.  
This event appears to be a true programmed cell death, albeit with atypical course of 
action.  The nurse cell remnants undergo transient autophagic activity followed by 
necrotic cell death based on autophagy markers and ultrastructure29.  Nurse cell death 
displays morphological features and markers consistent with necrosis including nuclear 
fragmentation, lysosomal rupture, increased cytoplasmic calcium, increased reactive 
oxygen species production, and activation of non-caspase proteases such as cathepsins24.  
However, the exact molecular mechanisms leading to this process are still unclear. 
The developing Drosophila eye has also shown promise as a model for novel cell 
death pathways, particularly in the elucidation of a TNF-mediated cell death pathway.  
The fly TNF homolog, Eiger, is able to kill at least partially through a caspase-mediated 
mechanism, although the exact contributions of caspase signaling and other pathways are 
still unclear.  Initial studies suggested that classical upstream activators of fly apoptosis, 
Reaper, Hid and Grim, were only partially responsible for killing30,31.  This result 
suggested that alternative cell death pathways were responsible for cell death.  
Mammalian TNF is capable of activating either apoptosis or necroptosis through 
diverging signaling pathways.  There are no fly homologs of the RIP family kinases and 
therefore no formal necroptosis in flies, but TNF-induced cell death in the fly eye appears 
to partially act through c-Jun N-terminal kinase (JNK) signaling32.  Furthermore, Reaper 
appears to specifically integrate into the TNF-JNK signaling axis by regulating 
Drosophila Inhibitor of Apoptosis 1 (DIAP1) which in turn regulates TNF receptor-
associated factor 1 (TNRF1)33.  Recently, Eiger mediated cell death has been found to act 
through energy production genes associated with the mitochondria31.  Mutants in the 
glycolysis pathway, β-oxidation, or the TCA cycle all modulated Eiger-JNK dependent 
cell death, suggesting the maintenance of energy levels plays a crucial role in regulating 
this pathway.  Importantly, this form of cell death cannot be blocked by loss of apoptosis 
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alone.  The pathways controlling the alternative cell death mechanism have yet to be 
elucidated. 
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Primary and Secondary Cell Death 
 
The current literature suggests that while necrosis may be genetically regulated, 
apoptosis is still the more common primary pathway by which cells are executed.   
However, there is evidence that other cell death pathways exist as backup mechanisms in 
case apoptosis or the primary cell death mechanism fails20,34.  In a highly sensitive 
fibrosarcoma cell line, activation of the death receptor Fas caused death in a caspase-
independent manner with necrotic morphology35, suggesting that a non-apoptotic 
mechanism could be killing these cells.  Stimulation of rat intestine epithelial cells with 
Tumor Necrosis Factor while blocking caspases pharmacologically resulted in necrotic 
cell death36.  Furthermore, in caspase-deficient Jurkat cells, artificial activation of a Fas 
effector caused necrotic cell death37.  In the aforementioned case of digit formation, 
apoptosis-deficient mice only exhibit a partial syndactyly phenotype, especially in 
comparison to severe mutations of developmental signaling pathways38,39.  This suggests 
that even if apoptosis fails, an alternative cell death pathway can removed the interdigital 
tissues during development.  These situations highlight the importance of backup or 
secondary mechanisms to trigger cell death if apoptosis is blocked. 
The existence of secondary cell death pathways leads to the question of whether 
all programmed cell death mechanisms have secondary cell death pathways.  In the 
Drosophila eye, TNF activated cell death appears to be only partially dependent on 
apoptosis31.  Thus, it is possible that if apoptosis were eliminated, a similar degree of cell 
death would occur via the secondary mechanism. 
Cell death in response to injury is another scenario in which having a secondary 
cell death mechanism would be valuable.  In situations where a cell is damaged beyond 
its ability to repair itself, cell death may be the most beneficial outcome.  A proliferating 
cell with DNA damage may eventually accumulate tumorigenic mutations.  One of the 
primary mechanisms by which cancers promote tumorigenesis and resist therapeutic 
intervention is by antagonizing cell death pathways, in particular apoptosis40,41.  It is 
likely that resistance to cell death is one of the clonally selected traits of cancers as they 
grow more aggressive.  Interestingly, the proportion of cancer cells that undergo non-
apoptotic cell death increases when apoptosis is blocked and the cells are treated with 
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conventional chemoradiation.  Thus, there has been heightened interest in discovering 
novel secondary cell death pathways and how to target them with anti-cancer drugs 
One of the most intensely studied areas of injury induced cell death is death in 
response to DNA damage or disruption of the cell cycle.  This has been motivated 
primarily by the need for better cancer therapies.  The p53 transcription factor is 
considered the guardian of the genome due to its roles in coordinating cell cycle arrest, 
DNA repair, and cell death.  The primary response to DNA damage involves cell cycle 
arrest or delay and DNA repair42,43.  Situations that require p53-mediated cell death are 
typically those involving such extreme cell damage or stress that normal repair 
mechanisms are no longer able to salvage the cell.  Understanding how p53 regulates the 
decision to promote cell death and the mechanisms that execute p53- mediated cell death 
can provide valuable insight into targeted cancer therapies. 
Drosophila p53 is similarly capable of inducing cell death in response to DNA 
damage.  Ionizing radiation or loss of telomeres are both capable of triggering p53-
mediated cell death44.  In Drosophila larval imaginal discs, p53 appears to bind to and 
activate the canonical apoptosis regulator gene loci reaper and hid43,45.  Over-expression 
of p53 leads to premature apoptosis.  Curiously, while mid-oogenesis germ cell death can 
be induced by p53 over-expression, co-expression of caspase inhibitors is unable to block 
germ cell death46.  This strongly suggests that an alternate mechanism exists to kill these 
germ cells.  The necrotic cell death pathways previously described in the developing 
oocyte stands as strong candidates for this alternative mechanism.  It is unclear why 
apoptosis would be suppressed or absent in p53-mediated cell death of the oocyte.  
Furthermore, the exact mechanism of cell death used in lieu of apoptosis has not been 
characterized.  However, these results indicate that cells incapable of dying via apoptosis 
are able to trigger a secondary mechanism to execute themselves.   
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The Drosophila Neuroblast 
 
 Stem cells function in development and adult tissues, generating all the functional 
cells of an organism and replacing old or damaged cells in tissue homeostasis47–49.  The 
stem cell field itself is multi-dimensional.  Many researchers in the field are interested in 
embryonic and induced pluripotent stem cells, which are thought to hold the keys to 
limitless tissue regeneration after injury and even immortality.  The similarities between 
cancer cells and stem cells have led to a whole new field based on the cancer stem cell 
hypothesis.  Central to all of these offshoots are the basic mechanisms that regulate stem 
cell self-renewal and differentiation. 
 One of the cardinal properties of stem cells is self-renewal, the ability to maintain 
stem cell identity after cell division.  The way stem cells maintain their viability and 
contend with cell stressors is critical to their ability to self-renew and maintain 
themselves, yet cell death in stem cells has received relatively little attention compared to 
the previously mentioned topics.  A better understanding of cell death in stem cells, 
particularly in response to damage or stress, can inform our studies of other aspects of 
stem cell biology.  Knowledge of cell death pathways could also allow us to modulate 
cell death and cell viability in various disease states such as cancer and 
neurodegeneration.   
 The Drosophila larval brain has been established as an excellent model system for 
studying stem cell biology50–53.  Each hemisphere of the fly central brain lobe contains 
exactly 100 neural stem cells (neuroblasts) which give rise to the majority of adult 
neurons responsible for behavior and motor function.  During larval development, each 
neuroblast continually divides asymmetrically to regenerate the neuroblast and produce a 
differentiating progeny.  Each cell type in the neuroblast lineage is easily identifiable by 
staining with antibodies specific for unique molecular markers.  The genetic tools built 
for fly research combined with the accessibility of this tissue have allowed us to gain a 
wealth of knowledge on the molecular mechanisms of asymmetric cell division, 
differentiation, and self-renewal.  Furthermore, many parallels exist between the 
developing nervous system of the fly and that of mammals51,54, suggesting that findings 
in the fly may be directly translatable to human biology. 
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 An unexplored area of neuroblast biology is the way they respond to damage.  
The central brain of the Drosophila larva carries an unusual burden: it must generate a 
large number of post-mitotic progeny in three to four days but can only produce them 
with 100 asymmetrically dividing neuroblasts.  This mode of division is limiting because 
the majority of neuroblasts can only produce one or two progeny with each division.  The 
neurons produced by larval neuroblasts are absolutely critical for the viability of the 
adult.  Therefore, the neuroblasts are biologically inclined to withstand as much cellular 
stress or damage as possible in order to maintain their proliferative rate.  The type of 
damage required to force the neuroblasts to either stop dividing or die has never been 
characterized.   
 A common result of irreparable damage to cells is death.  It is well established 
that catastrophic DNA damage can lead to p53-mediated apoptosis in certain cell types.  
Very little is known about its regulation of cell damage and cell death in central brain 
neuroblasts.  The neuroblasts of the embryonic ventral nerve cord, the other half of the 
central nervous system of fly, have been shown to die by canonical apoptosis before 
entering the larval stages55.  Most of the neuroblasts in the ventral nerve cord typically do 
not survive in the larvae and are programmed to die before the larval stages.  The death of 
these ventral nerve cord neuroblasts is controlled by the pro-apoptotic genes reaper, hid 
and grim.  These genes regulate cell death primarily by inhibiting the Drosophila 
inhibitor of apoptosis (DIAP).  The central brain neuroblasts are also programmed to die 
by apoptosis at the end of larval development and before pupation56.  Curiously, before 
these neuroblasts die, the apoptosis machinery is suppressed by Polycomb group 
proteins57.  Thus, while central brain neuroblasts can be eliminated by apoptosis at the 
right time, they may not be competent to undergo apoptosis before that time.  However, 
secondary cell death mechanisms may function to eliminate damaged cells even in the 
absence of apoptosis.   
 One of the main advances presented in this thesis are on how Drosophila larval 
central brain neuroblasts may be maintained through a pro-survival mechanism that is 
distinct from classical self-renewal pathways.  Furthermore, this survival mechanism may 
represent a secondary, non-apoptotic, programmed cell death that lies downstream of the 
neuroblast response to catastrophic cellular damage. 
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Figure 1.1. Evolutionary Conservation of the Core Apoptotic Machinery58. 
A comparison between the apoptotic pathways in C. elegans, Drosophila, and mammals 
reveals conservation and expansion of the apoptotic pathway during evolution.  (A) In 
C. elegans, apoptotic signals regulate the interplay between Egl-1 (BH3-only homology) 
and CED-9 (Bcl-2 homolog), liberating CED-4 (Apaf-1 homolog) to activate CED-3 
(caspase-9 homolog) for programmed death of 131 cells.  (B) In Drosophila, many 
different signaling pathways regulate the IAP antagonists Reaper, Hid, and Grim (RHG) 
and the apoptosome proteins Ark (Apaf-1 homolog) and Dronc (caspase-9 homolog).  On 
the one hand, this causes the ubiquitin-mediated degradation of DIAP1 and derepression 
of caspases, and on the other hand, it enables Dronc (caspase-9 homolog) to associate 
with Ark, creating active apoptosomes and activation of the effector caspases DrICE and 
Dcp1.  Both pathways are required for efficient caspase activation and are coordinately 
regulated.  The P35 baculovirus protein can specifically inhibit the activity of Dcp-1 and 
DrICE.  (C) In mammals, the balance between proapoptotic and antiapoptotic Bcl-2 
family members is a key factor in the commitment to apoptosis by regulating the release 
of cytochrome c and IAP antagonists from mitochondria.  Binding of cytochrome c to 
Apaf-1 promotes apoptosome assembly, which recruits and activates caspase-9.  IAP 
antagonists liberate caspases from the inhibition of IAPs, most notably X-linked inhibitor 
of apoptosis (XIAP), which targets both initiator and effector caspases.  The XIAP 
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antagonist ARTS is localized to the mitochondrial outer membrane and acts prior to the 
release of cytochrome c, Smac, and other proteins released from the mitochondrial 
intermembrane space.  Homologous proteins (by either function or sequence) are 
similarly illustrated.  
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Figure 1.2. Major apoptotic pathways in mammalian cells59. 
The extrinsic pathway and intrinsic pathway both act through mitochondrial signals, 
although the extrinsic pathway also has a major extra-mitochondrial component.  The 
intrinsic pathway can be stimulated by numerous agents, all resulting in release of 
cytochrome c from the mitochondria by removing the repressive effect of B-cell 
lymphoma 2 protein (Bcl-2).  Cytochrome c complexes with apoptotic protease activating 
factor 1 (Apaf-1) and recruits and activates caspase-9, forming the active apoptosome.  
The apoptosome activates the effector caspase-3 to initiate killing.  The extrinsic pathway 
begins with signaling to a death receptor such as Fas to Fas ligand (FasL).  Subsequent 
interaction of the death receptor intracellular domains with scaffolding subunits such as 
Fas-associated death domain (FADD) allows for recruitment of Procaspase-8 and 
formation of the death-inducing signaling complex (DISC).  Fas is a member of the 
tumor necrosis factor superfamily.  Activated caspase-8 promotes activation of caspase-3 
directly.  Caspase-8 also activates caspase-3 indirectly through the intrinsic pathway by 
activating the protein Bid, which then promotes release of cytochrome c.  
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Figure 1.3. Regulated Necrosis20. 
Upon tumor necrosis factor α (TNFα) binding, the cytoplasmic tails of TNF receptor 1 
(TNFR1, a prototypic death receptor) trimers recruit TNFR-associated death domain 
(TRADD), receptor-interacting protein kinase 1 (RIP1), cellular inhibitor of apoptosis 1 
(cIAP1), cIAP2, TNFR-associated factor 2 (TRAF2) and TRAF5.  Within the so-called 
complex I, RIP1 is polyubiquitinated by cIAPs, thereby providing a docking site for the 
recruitment of transforming growth factor β (TGFβ)-activated kinase 1 (TAK1), TAK1-
binding protein 2 (TAB2) and TAB3 (which together deliver a pro-survival signal by 
activating the transcription factor NF-κB).  In some pathophysiological and experimental 
settings, and in particular when caspase-8 is absent or when caspases are inhibited by 
pharmacological agents, cylindromatosis (CYLD)-deubiquitinated RIP1 engage in 
physical and functional interactions with its homolog RIP3, ultimately activating necrotic 
cell death.  Regulated necrosis can also be induced by alkylating DNA damage (possibly 
by the overactivation of poly(ADP-ribose) polymerase 1 (PARP1).  In some instances, 
regulated necrosis requires the kinase activity of RIP1, that is, it can be blocked by the 
RIP1-targeting compounds necrostatins.  
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Summary 
 
Precise regulation of stem cell survival is essential to ensure continuous 
generation of differentiated progeny throughout the lifetime of an organism. However, 
cell viability is generally perceived as the consequence of the stem cell self-renewal 
program rather than the output of a dedicated cell survival mechanism. Here, we describe 
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a novel mechanism elicited by Cdc20/Fizzy (Fzy) that maintains the viability of neural 
stem cells (neuroblasts) in the fly larval brain. We identify two novel fzy mutations that 
specifically lead to premature loss of neuroblasts without affecting the viability and the 
proliferation of other diploid cell types. Unexpectedly, neuroblasts carrying either fzy 
mutation display morphological and functional characteristics indicative of necrotic cell 
death. Consistently, removing genes required for the activation of apoptosis or autophagy 
fail to suppress neuroblast loss in fzy mutant brains. Fzy maintains neuroblast viability via 
a novel anaphase promoting complex-dependent mechanism. Inactivating the function of 
apoptosis inducing factor (aif) or JNK signaling significantly prolong the survival of fzy 
mutant neuroblasts, indicating that Fzy maintains neuroblast viability by antagonizing 
these signaling mechanisms. Finally, neuroblasts exhibiting centrosomal defects or 
activated DNA damage response also undergo necrotic cell death, indistinguishable from 
fzy mutant neuroblasts. We propose that in response to catastrophic damage, the Fzy-
dependent cell survival mechanism eliminates stem cells by necrotic cell death via 
multiple cell cycle checkpoints during fly larval brain neurogenesis.  
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Introduction 
 
Stem cells need to maintain their identity and remain viable in order to generate 
sufficient numbers of differentiated progeny during development and homeostasis.  The 
mechanisms that maintain the identity of stem cells allow them to retain extended 
developmental potential and proliferative capacity1–3.  By contrast, maintenance of cell 
viability is generally perceived as the consequence of the mechanisms that maintain stem 
cell identity rather than a dedicated program that promotes stem cell survival.  As such, 
specific mechanisms that preserve stem cell pools by promoting cell survival remain 
unknown.  Mechanistic insight into the control of stem cell viability can potentially 
improve the efficiency of manipulating stem cells for tissue engineering and lead to the 
development of novel therapies for targeting tissue-specific tumor stem cells. 
A Drosophila larval brain lobe maintains a steady 100 neuroblasts which can be 
unambiguously identified by the expression of various cell fate markers and provides a 
genetic model system for investigating the regulation of neural stem cells in vivo4–6.  
Neuroblasts in the larval brain undergo rapid and successive asymmetric divisions to give 
rise to adult-specific neurons and glia.  A previous study shows that the Polycomb group 
genes are required to prevent larval brain neuroblasts from prematurely undergoing 
apoptosis7.  However, the Polycomb group genes have pleiotropic functions and can 
regulate a wide array of downstream signaling mechanisms8–10.  Specific downstream 
mechanisms by which the Polycomb group genes prevent premature onset of apoptosis in 
neuroblasts remain unknown.  Furthermore, the roles of other forms of programmed cell 
death such in the maintenance of larval brain neuroblasts have never been established. 
Cdc20/Fzy plays an evolutionarily conserved role in eliciting the functions of the 
Anaphase-Promoting Complex/Cyclosome (APC/C) complex11–13.  The APC/C complex 
functions as an E3 ubiquitin ligase and targets its substrates for ubiquitin-dependent 
protein degradation.  Cdc20/Fzy recognizes and recruits APC/C substrates through its 
carboxyl-terminal WD40 repeats14,15.  A recent structural study on the substrate-bound 
WD40 repeats of yeast Cdc20 reveals that two of these repeats mediate its physical 
interaction with the canonical mitotic substrates of the APC/C complex16.  Cdc20 elicits 
the function of APC/C in many cellular processes other than cell cycle progression 
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presumably by recognizing and recruiting various substrates17–19.  How Cdc20 exerts 
substrate recognition and recruitment in non-cell cycle contexts remain unknown.  For 
example, do the WD40 repeats that mediate the binding to mitotic regulatory proteins 
also function to recognize and recruit other APC/C substrates?  Alternatively, could 
distinct WD40 repeats recognize and recruit unique APC/C substrates?  
 In this study, we describe a novel Fzy-dependent mechanism that preserves the 
neuroblast pool during larval brain neurogenesis by promoting cell viability.  Through 
functional analyses of two novel fzy mutant alleles, we identified residues glycine291 and 
alanine444 as being specifically required for Fzy-dependent neuroblast maintenance.  
The analogous residue to glycine291 of fly Fzy is also dispensable for the function of 
vertebrate Cdc20 in promoting cell cycle progression.  Furthermore, fzy mutant 
neuroblasts did not display diagnostic characteristics of mitotic catastrophe induced by 
defects in the degradation of the mitotic substrates of APC/C, Cyclin A or B.  Thus, Fzy 
maintains neuroblasts via a mechanism independent of its role in regulating cell cycle 
progression.  Mutant phenotypic analyses revealed that the nuclei of many fzy mutant 
larval brain neuroblasts lacked DNA content and prompted us to investigate how these 
neuroblasts die.  Surprisingly, functional and morphological analyses indicated that Fzy 
maintains neuroblasts by suppressing necrotic cell death via an APC/C-dependent 
mechanism.  Since the fly genome lacks functional orthologs of the canonical regulators 
of programmed necrosis, Fzy most likely suppresses necrotic cell death via a novel 
mechanism.  Indeed, we found that removing aif function or inactivating JNK signaling 
prolongs the survival of fzy mutant neuroblasts whereas ectopically activating JNK 
signaling induces premature necrotic cell death in neuroblasts.  Ectopic induction of 
DNA damage or cell cycle perturbation led to necrotic cell death of the neuroblasts with 
similar marker expression as the Fzy.  Finally, these mutations also lead to loss of Fzy 
expression, suggesting that they induce neuroblast necrosis via loss of Fzy.  Altogether, 
our results demonstrate that the novel Fzy-dependent mechanism maintains neuroblasts 
by promoting cell survival during larval brain neurogenesis.  Furthermore, this 
mechanism may be a common pathway by which catastrophic cellular damage is 
translated into cell death. 
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Materials and Methods 
 
Drosophila culture and genetics 
All Drosophila stocks were maintained on yeast-glucose fly media.  Embryos were 
collected on apple juice agar supplemented with yeast paste.  Larvae were transferred to 
cornmeal agar at 0 ALH.  In all experiments, heterozygous larvae with balancers were 
used as controls, since none of these animals had any detectable phenotypes at any stage.  
Mosaic clones were generated following previously published protocols20.  The fzy5032 
mutant allele was isolated from an unbiased EMS mutagenesis.  The following mutations 
were used in this study: fzy1, fzy4 and fzyAC-10 21,22, dreddB118 23, atg1 mutant alleles (unc-
513 and unc-5125) 24, apc2 mutant alleles (mr3 and mr4) 25, apc11 (lmg138) 26, aif (aifKO)27, 
egr1 28, bsk1 22, dronc (Nc51) 29, ark82 30, p535A-1-4 31, apc10e01070 and apc6 (cdc16MB09129)32, 
apc5 (idaB4 and idaD14)33, pink1B8 34. The following transgenic fly lines were used in this 
study UAS-cycAΔ170 and hs-cycBS 35, puc-lacZ (pucE69) 36, gfp-atg8a 37, UAS-GCaMP3.0 
38, UAS-apoliner 39, UAS-p35 40, UAS-dtak1, UAS-dtak1DN, UAS-ask1 41. The following 
stocks were obtained from the Bloomington Drosophila Stock Center, hs-flp, Elav-
Gal4Tub-Gal4, UAS-mCD8-GFP, FRT40A, Tub-Gal80, Df(3L)BSC283, 
Df(2R)Exel6065, Df(2R)Exel7157, Df(2R)BSC355, Df(3L)ED4341, Df(3R)Exel9012, 
Df(2L)Exel7038. The following stocks were obtained from the Vienna Drosophila RNAi 
Center, UAS-ND42RNAi (14444) and UAS-ND75RNAi (52047).  
 
EdU Assay 
EdU labeling of proliferating larval tissues were performed following a previously 
established protocol42. 
 
Protein structure modeling 
All sequence alignments were performed using MegAlign version 8.1.4(7).414 by 
DNASTAR and Clustal W alignment method.  S. pombe Slp-1 (CDC20) crystal structure 
PDB code: 4AEZ 43.  Structure analysis and modeling were performed using UCSF 
Chimera, alpha version 1.5 (build 31214). 
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Light Photography and Filming 
Anterior pupal cases were removed from pharate adults to expose heads.  The samples 
were examined using a Leica MZ95 stereomicroscope.  Images and video were acquired 
using a Sony Handycam HDR-SR1.  Images were processed using Microsoft Photoshop 
CS3. 
 
Immunofluorescence staining and imaging 
Larval brains were processed for immunofluorescent staining following a standard 
protocol44.  The following primary antibodies were used: rat anti-Dpn (1:1000), rabbit 
anti-Mira (1:1000), mouse anti-Pros (1:100), chicken anti-GFP (1:2000, GFP-1020, Aves 
Labs), mouse anti-Fzy (1:20), mouse anti-Lamin (1:400, ADL67.10, DSHB), mouse anti-
phospho-histone H3 (1:2000, 3H10, Upstate), mouse anti-CycB (1:50, F2F4, DSHB), 
mouse anti-Elav (1:100, 9F8A9, DSHB), mouse anti-ATP5A (1:500, MS507, Abcam), 
rabbit anti-Phospho-SAPK/JNK (1:100, 9251, Cell Signaling).  Secondary antibodies 
were from Invitrogen and Jackson Labs (details are available upon request).  We used 
AlexaFluor 488 phalloidin (1:100, A12379, Invitrogen), rhodamine phalloidin (1:100, 
R415, Invitrogen).  The following small molecules were used: Hoechst 33342 (2 µg/mL, 
C10340 COMPONENT G, Invitrogen), Necrostatin-1 (various concentrations, BML-
AP309, Enzo Life Sciences).  For DHE staining, brains were dissected in PBS, incubated 
in DHE (1:1000, 30 µM, gift from Craig Byersdorfer) for 5 minutes at room temperature 
with rocking, washed in PBS for 5 minutes with rocking, and immediately mounted for 
imaging with PBS on glass slides.  Samples were examined using a Leica TCS SP5 
scanning confocal microscope system operated using LAS AF v.2.6.0.7266. 
 
Quantitative PCR 
RNA was isolated from 4 to 6 larvae per genotype aged for 96 hours after hatching using 
the Trizol (Gibco) reagent following manufacturer’s suggested protocol.  Primers used 
for qPCR: fzy1for (TCCACAAAGAGTGGCTCACGC), fzy1rev 
(CAAATAGACGCAACTGCCCAAGG), fzy2for 
(GCTGGAGGCGTCTCTAAATGGA), fzy2rev (GGGCGTGGTGTTGGACTT), rp49for 
(ATCGGTTACGGATCGAACAA), rp49rev (GACAATCTCCTTGCGCTTCT).  
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Transmission electron microscopy 
Larval brains were fixed in 2.5% glutaraldehyde in 0.1 M Sorensen’s buffer, pH 7.4, 
overnight at 4oC.  After several buffer rinses, they were post-fixed in 1% osmium 
tetroxide in the same buffer.  They were then rinsed in double distilled water to remove 
phosphate salt and then en bloc stained with aqueous three percent uranyl acetate for 1 
hour.  They were dehydrated in ascending concentrations of ethanol, rinsed two times in 
propylene oxide, and embedded in epoxy resin.  The samples were ultra-thin sectioned 70 
nm in thickness and stained with uranyl acetate and lead citrate.  The sections were 
examined using a Philips CM100 electron microscope at 60 kV.  Images were recorded 
digitally using a Hamamatsu ORCA-HR digital camera system operated using AMT 
software (Advanced Microscopy Techniques Corp., Danvers, MA).  Images were 
processed using Adobe Photoshop CS3.  
 
Histology 
Larvae were allowed to pupate and develop at 25°C.  Anterior pupal cases were removed 
from pharate adults to expose heads and whole pupae were fixed in 1% glutaraldehyde, 
4% formaldehyde, acid and alcohol, overnight at 4oC.  The samples were washed in 80% 
ethanol, dehydrated in ascending concentrations of ethanol, washed in xylenes, and 
embedded in paraffin. 5 µm sections were obtained and stained with Mayer’s 
hematoxylin and eosin.  The sections were examined using a Leica DM5000 B upright 
microscope equipped with a QImaging Retiga 2000R camera.  Images were acquired 
using QCapture Pro v.5.1.1.14 software (Media Cybernetics, Inc.). 
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Results 
 
Fzy maintains neuroblasts independently of its role in promoting cell cycle 
progression  
From a genetic screen, we identified two novel fzy mutant alleles, fzy5032 and 
fzyAC-10, that specifically lead to premature loss of larval brain neuroblasts.  Larvae that 
were fzy5032 or fzyAC-10 homozygous or in trans with the fzy1 null mutant allele showed 
similar patterns of brain neuroblast loss and developed into adults that exhibited poor 
motor coordination likely due to a dramatic reduction in neuron production (Fig. 2.1A-K; 
data not presented).  The neuroblast loss phenotype in the fzy5032 or fzyAC-10 mutant brains 
could be completely rescued by neuroblast-specific over-expression of a UAS-fzy 
transgene or a transgene containing the fzy genomic locus (Fig. 2.2A; data not presented).  
Thus, the fzy5032 and fzyAC-10 mutations are strong loss-of-function mutant alleles.  The 
fzy5032 mutation led to the substitution of glycine291 with arginine whereas the fzyAC-10 
mutation resulted in the substitution of alaine444 with valine (Fig. 2.2B).  Most GFP-
marked lineage clones derived from single neuroblasts mutant for fzy5032 or fzy4, a fzy null 
mutant allele45, lacked neuroblasts and contained far fewer cells than the similarly staged 
control clones (Fig. 2.1L-N,Z).  Hence, the fzy5032 mutation acts as a genetic null allele in 
the context of neuroblast maintenance, and we focused the rest of this study on the fzy5032 
allele.  Consistent with the molecular lesion, fzy5032 homozygous mutant larvae displayed 
a similar level of fzy transcript and a similar expression pattern of Fzy protein as fzy5032/+ 
control larvae (Fig. 2.2C-E).  Thus, premature loss of neuroblasts in the fzy5032 mutant 
brain is most likely due to loss of Fzy protein function rather than a reduced fzy mRNA 
level or reduced Fzy protein stability. 
Although the role of Fzy in regulating cell cycle progression is evolutionarily 
conserved, all adult-specific structures except the brain and bristles developed fully in the 
newly eclosed fzy5032 homozygous mutant flies (Fig. 2.1H-K; Fig. 2.2F-H).  The lack of 
bristles may indicate a shared mechanism between neuroblasts and bristle progenitors, 
which are also of proneural developmental origin.  Thus, we hypothesized that Fzy 
maintains central brain neuroblasts via a mechanism independent of its role in promoting 
cell cycle progression.  Consistently, lineage clones derived from single fzy5032 mutant 
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optic lobe neuroepithelial cells contained similar numbers of optic lobe neuroblasts as 
wild-type clones (Fig. 2.1S-T).  By contrast, fzy4 null mutant neuroepithelial cell clones 
never exceeded a single cell in size, indicating that fzy function is essential for their 
expansion (Fig. 2.1U).  These data indicate that the mutant Fzy protein carrying the 
G291R substitution function similarly to wild-type Fzy in promoting symmetric 
expansion of optic lobe neuroepithelial cells.  In addition, fzy5032 mutant larval imaginal 
disc cells or adult intestinal stem cells underwent clonal expansion similarly to wild-type 
cells while fzy4 mutant cells failed to expand (Fig. 2.2I-N).  This result led us to conclude 
that the fzy5032 mutation specifically perturbs central brain neuroblast maintenance but 
does not abolish the proliferation of other cell types.  We extended our analyses by 
testing whether the mutant vertebrate Cdc20 protein bearing an analogous amino acid 
substitution as the mutant Fzy protein carrying the G291R substitution can promote cell 
cycle progression (Fig. 2.2O).  Indeed, expression of the mutant fly or mouse Cdc20 
protein rescued the cell cycle arrest phenotype in fzy4 optic lobe clones (Fig. 2.1U-Y, 
AA).  However, consistent with earlier results, expression of mutant Cdc20 was unable to 
rescue the small clone size of fzy4 central brain neuroblast clones (Fig. 2.1N-R, Z).  
Therefore, the G291R substitution induced by the fzy5032 mutation specifically abolishes 
the function of Fzy in maintaining central brain neuroblasts without removing its ability 
to promote cell proliferation. 
To more closely examine the kinetics of neuroblast loss due to the fzy mutants, we 
examined fzy5032 and fzy4 mutant neuroblast mosaic clones 24 hours after clone induction. 
At this time point, the frequency of central brain clones had already been reduced 
drastically in mutant clones compared to wild-type (Fig. 2.2P).  Since the vast majority of 
central brain clones are derived from neuroblasts, this result suggests that a significant 
number of fzy mutant neuroblasts disappeared within 24 hours of clone induction.  
Furthermore, a larger percentage of the remaining mutant clones lacked a neuroblast as 
compared to wild-type, arguing that a large number of fzy mutant neuroblasts which 
remained long enough to produce progeny disappeared within 24 hours as well (Fig. 
2.2Q).  These results are consistent with the observation that neuroblasts are lost within 
the first 24 hours of larval development in fzy5032 and fzyAC-10 mutant brains.  Taken 
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together, these data demonstrate that fzy mutant neuroblasts disappear rapidly within the 
first 24 hours that fzy function is lost, and many disappear before producing progeny. 
 
Neuroblast loss in the fzy5032 mutant brain unlikely occurs due to mitotic arrest 
 Fzy elicits the function of APC/C in promoting cell cycle progression by 
recruiting mitotic regulatory proteins for ubiquitin-dependent protein degradation46.  
Thus, we tested if loss of neuroblasts in the fzy5032 mutant brain occurs through mitotic 
catastrophe triggered by aberrant accumulation of APC/C substrates47,48.  Since Fzy 
shares greater than 50% amino acid identity with yeast CDC20, we first modeled the 
location of glycine291 relatively to the surfaces that mediate the interaction between 
yeast Cdc20 and the mitotic substrates of APC/C.  A recent structural study reveals that 
the binding between yeast Cdc20 and the mitotic substrates of APC/C mainly occurs 
through residues located amino terminal to the first WD40 repeat as well as in the first 
WD40 repeat itself49.  By contrast, the analogous residue for glycine291 is located in the 
third WD40 repeat and is not involved in binding to the mitotic substrates of APC/C (Fig. 
2.3A).  Furthermore, glycine291 is located in a loop between two β-sheets, so the G291R 
substitution induced by the fzy5032 mutation is predicted not to perturb the overall tertiary 
structure of the WD40 repeat.  Thus, the Fzy mutant protein induced by the fzy5032 
mutation should fulfill its role in the recruitment of mitotic substrates to the APC/C 
complex. 
 The structural modeling of the G291R substitution strongly supported our 
hypothesis that neuroblast loss in the fzy5032 mutant brain unlikely occurs due to aberrant 
accumulation of known APC/C substrates.  We directly tested this hypothesis by over-
expressing a non-degradable form of Cyclin A or B, the canonical substrates of APC/C 
during mitosis, in neuroblasts.  All neuroblasts in the fzy5032/+ control brain expressed 
Dpn and lacked the expression of neuronal marker Elav (Fig. 2.3B).  Furthermore, every 
neuroblast in the control brain maintained 10-12 µm in diameter and possessed a single 
nucleus containing DNA (Fig. 2.3C-D).  Additionally, the level of Cyclin A and B 
expression varied between neuroblasts due to their asynchronous cell cycle stages (Fig. 
2.3B-D; data not presented).  Neuroblasts mis-expressing non-degradable Cyclin A or B 
showed an identical combination of cell identity marker expression as control neuroblasts 
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but displayed hallmarks of mitotic catastrophe.  Specifically, these mutant neuroblasts 
became drastically enlarged, possessed multiple nuclei per neuroblast that each contained 
constitutively condensed chromosomes and showed aberrant accumulation of Cyclin A 
and B (Fig. 2.3E-G; data not presented).  By contrast, neuroblasts in the fzy5032 mutant 
brain never became enlarged and multi-nucleated and never showed aberrant Cyclin A 
and B accumulation (Fig. 2.3H-J; data not presented).  Most strikingly, neuroblasts in the 
fzy5032 mutant brain lacked detectable nuclear DNA, and fzy5032 mutant brains contained 
far fewer neuroblasts than larval brains expressing non-degradable Cyclin A or B (Fig. 
2.3H-K; data not presented).  Thus, we conclude that the neuroblast loss phenotype in the 
fzy5032 mutant brain unlikely occurs due to mitotic arrest or an inability to degrade mitotic 
APC/C substrates. 
 
Fzy maintains neuroblasts by suppressing necrotic cell death 
Thus far, our data showing loss of DNA in fzy5032 mutant neuroblasts strongly 
suggested they undergo premature cell death and prompted us to investigate the cell death 
mechanisms underlying neuroblast loss in the fzy5032 mutant brain.  We first tested if 
activation of apoptosis contributes to neuroblast loss in the fzy5032 mutant brain.  
However, we did not detect activation of caspases in fzy5032 mutant neuroblasts by using 
an in vivo caspase reporter protein50, and over-expressing the caspase inhibitor p35 
protein40 did not prevent neuroblast loss in the fzy5032 mutant brain (data not presented).  
Furthermore, removing the genes encoding the core component of the apoptosome51 or 
the apical activator caspase29,52 also did not suppress neuroblast loss in the fzy5032 mutant 
brains (Fig. 2.4A).  Thus, fzy5032 mutant neuroblasts did not undergo premature apoptosis.  
We next tested if Fzy maintains neuroblasts by suppressing autophagy.  Despite increased 
expression of the autophagic vacuole marker GFP-Atg8a37 in some neuroblasts in the 
fzy5032 mutant brain compared to neuroblasts in control brains, we never detected GFP-
Atg8a localized in discrete puncta indicative of autophagosome formation (data not 
presented).  Additionally, removing the function of the atg1 or atg7 gene required for 
autophagy53,54 did not prevent neuroblast loss in the fzy5032 mutant brains (Fig. 2.4A).  
Therefore, fzy5032 mutant neuroblasts did not undergo premature autophagy.  Altogether, 
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these data led us to conclude that Fzy likely maintains neuroblasts by suppressing a novel 
form of programmed cell death. 
To investigate how fzy5032 mutant neuroblasts die, we characterized their 
morphological changes by transmission electron microscopy.  Neuroblasts in the fzy5032/+ 
control brain always contained single large nuclei, and their cytoplasm were filled with 
organelles including mitochondria, ribosomes and endoplasmic reticulum (Fig. 2.4B-B’).  
By contrast, neuroblasts in the fzy5032 mutant brain often did not have identifiable nuclei, 
and their cytoplasm appeared largely devoid of organelles and vacuoles (Fig. 2.4C-C’).  
Remnants of the endoplasmic reticulum aggregated with remaining mitochondria into 
electron dense masses (Fig. 2.4C’).  Mitochondria in fzy5032 mutant neuroblasts appeared 
swollen and lost their integrity, and their membranes became ruptured (Fig. 2.4C’).  
These morphological changes strongly resembled those displayed by cells undergoing 
necrotic cell death48,55.  Consistent with their morphological changes, mitochondria 
became aggregated in 25% of the remaining fzy5032 mutant neuroblasts but are evenly 
interspersed in fzy5032/+ control neuroblasts (Fig. 2.4D-F).  In addition, we detected a high 
level of reactive oxygen species (ROS) in the cytoplasm of 65% of fzy5032 mutant 
neuroblasts while only 3% of fzy5032/+ control neuroblasts showed similar cytoplasmic 
ROS (Fig. 2.4G-I).  Greater than 50% of fzy5032 mutant neuroblasts displayed a high level 
of cytoplasmic calcium ions whereas less than 1% of fzy5032/+ control neuroblasts showed 
similarly elevated cytoplasmic calcium ions (Fig. 2.4J-L).  Finally, almost 40% of fzy5032 
mutant neuroblasts contained ubiquitin-conjugated protein aggregates which were 
virtually nonexistent in fzy5032/+ control neuroblasts (Fig. 2.4M-O).  The combination of 
morphological features and marker expression led us to conclude that fzy5032 mutant 
neuroblasts undergo necrotic cell death. 
 
Fzy maintains neuroblasts by suppressing necrotic cell death via an APC/C-
dependent mechanism  
The role of Fzy in substrate recognition and recruitment for the APC/C complex 
is evolutionarily conserved11–13.  Thus, we tested if Fzy suppresses necrotic cell death in 
neuroblasts via an APC/C-dependent mechanism.  Larval brains mutant for either the 
scaffolding, catalytic, or substrate recruitment subunits of the APC/C complex all showed 
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a reduction in central brain neuroblasts (Fig. 2.5B-G, Z)25,26,56–58.  Distinct from the 
fzy5032 mutant, however, the expansion of neuroepithelial cells in the apc mutant optic 
lobes became prematurely arrested (Fig. 2.5B-G).  Thus, APC/C function is essential for 
both neuroblast maintenance as well as the expansion of neuroepithelial cells.  To 
confirm that the APC/C complex indeed maintains neuroblasts by suppressing necrosis, 
we examined whether APC/C mutant neuroblasts displayed similar marker expression as 
fzy5032 mutant neuroblasts.  Indeed, neuroblasts carrying an APC/C mutation exhibited 
aggregation of mitochondria, increased cytoplasmic ROS and increased cytoplasmic 
calcium ions (Fig. 2.5H-Y).  Thus, the function of APC/C is essential for maintaining 
neuroblasts as well as promoting the proliferation of neuroepithelial cells.  These data are 
consistent with fzy mutant phenotypic analyses and strongly suggest that the fzy5032 
mutation specifically disrupts the role of Fzy in eliciting the function of APC/C in 
neuroblast maintenance. 
  
Necrosis markers are not sufficient for cell death execution 
 The presence of necrosis markers led us to examine these markers’ relationship to 
neuroblast necrosis in detail.  In order to investigate whether the markers are functionally 
important for neuroblast necrosis, we examined mutations that elicit each of the necrosis 
markers individually and determine if the presence of the marker was sufficient for cell 
death.  The Pten-induced putative kinase 1 (pink1) gene regulates mitochondrial fission 
and fusion34,59,60.  However, larval brains mutant for the pink1 contained a similar number 
of neuroblasts as control brains (Fig. 2.6A-B, D).  Moreover, knocking down the function 
of ND75 or ND42 genes, which encode components of the mitochondrial respiratory 
chain61, triggered a massive increase in the level of cytosolic ROS but failed to induce 
premature neuroblast loss in the larval brain (Fig. 2.6C-D).  Thus, neither mitochondrial 
dysfunction nor increased ROS production alone appears sufficient to induce premature 
neuroblast loss.  Next, we examined the contribution of ubiquitin-conjugated aggregates.  
Mutations in transactive response DNA-binding protein 43 (TDP-43) and valosin 
containing protein (VCP) mutations have been associated with neurodegenerative 
diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration in 
which ubiquitinated inclusion bodies are a signature pathological feature.  Over-
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expression of either a pathologic form of TDP-43 or VCP caused increased frequency of 
ubiquitin-conjugated aggregates (Fig. 2.6E-G, I).  However, neither mutation was 
sufficient to cause loss of neuroblasts (Fig. 2.6D).  Finally, over-expression of dominant 
negative components of the proteosome complex also caused the presence of ubiquitin-
conjugated aggregates, presumably by blocking the ability of proteasome complex to 
degrade ubiquitin-conjugated proteins (Fig. 2.6H-I).  This mutation also did not kill 
neuroblasts (Fig. 2.6D).  Thus, despite the presence of individual necrosis markers in 
these mutants, none of them caused necrosis of neuroblasts.  Taken together, these data 
suggest that mitochondrial dysfunction, oxidative stress, and protein stress are not 
individually sufficient to induce necrosis of neuroblasts.  
 
Fzy maintains brain neuroblasts by suppressing a non-canonical necrotic cell death 
mechanism 
Lack of detectable DNA in fzy5032 mutant neuroblast nuclei strongly suggested 
that a robust endonuclease activity might contribute to neuroblast loss in the fzy5032 
mutant brain.  The aif gene encodes a mitochondrial oxidoreductase protein and upon 
activation, can recruit an endonuclease complex to trigger large-scale DNA 
fragmentation62,63.  An aif mutant mosaic clone contained a single neuroblast and 
possessed many neuronal progeny, indistinguishable from a wild-type neuroblast clone 
(Fig. 2.7A, C).  This result indicates that aif is dispensable for the maintenance and the 
proliferation of neuroblasts.  By contrast, removing aif function significantly prolonged 
the survival of fzy5032 mutant neuroblasts allowing them to generate more neuronal 
progeny compared identically staged fzy5032 mutant neuroblasts alone (Fig. 2.7B-E).  
Thus, necrotic cell death of fzy5032 mutant neuroblasts requires aif function.  Over-
expression of a truncated Aif transgenic protein lacking the amino terminal mitochondrial 
localization domain but not the wild-type Aif transgenic protein can trigger caspase 
activation and cell death in larval eye imaginal disc cells27,63.  However, over-expression 
of neither the truncated nor the wild-type Aif transgenic protein was sufficient to induce 
premature loss of neuroblasts (data not presented).  This result is consistent with our 
results indicating that fzy5032 mutant neuroblasts undergo necrotic cell death rather than 
apoptotic cell death.  Together, these data led us to conclude that aif function is required 
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for necrotic cell death of fzy5032 mutant neuroblasts but additional caspase-independent 
downstream mechanisms must exist.  
Activation of c-Jun N-terminal kinase (JNK) signaling was previously shown to 
coincide with increased ROS production in necrotic cells in vertebrates and in non-
apoptotic cell death in the fly64–67.  To test whether aberrant activation of JNK signaling 
might contribute to neuroblast loss in the fzy5032 mutant brain, we examined the 
expression of puc-lacZ and the phosphorylated form of JNK.  The expression of puc-lacZ 
and phosphorylated JNK was undetectable in neuroblasts in the fzy5032/+ mutant brain, 
indicating that JNK signaling is not activated in control neuroblasts (Fig. 2.7F; data not 
presented).  By contrast, we consistently detected the expression of both puc-lacZ and 
phosphorylated JNK in many neuroblasts in the fzy5032 mutant brain (Fig. 2.7G; data not 
presented).  Thus, JNK signaling becomes aberrantly activated in fzy5032 mutant 
neuroblasts.  We next tested if neuroblast loss in the fzy5032 mutant brain required the 
function of JNK encoded by the basket (bsk) gene.  A bsk mutant mosaic clone 
maintained a single neuroblast and possessed as many neuronal progeny as a wild-type 
neuroblast clone (Fig. 2.7A, I).  This result indicates that bsk is dispensable for the 
maintenance and the proliferation of neuroblasts.  By contrast, removing bsk function 
from fzy5032 mutant neuroblasts allowed them to generate more neuronal progeny 
compared to identically staged fzy5032 mutant neuroblasts alone (Fig. 2.7I-K).  This 
suggests that loss of bsk prolonged the survival of fzy5032 mutant neuroblasts which 
allowed them to produce significantly more progeny.  Thus, necrotic cell death of fzy5032 
mutant neuroblasts requires bsk function.  To complement the loss-of-function analyses, 
we examined whether aberrant activation of JNK signaling is sufficient to induce 
premature necrotic cell death of neuroblasts.  Previous studies showed that the JNK 
kinase kinase (JNKKK) encoded by the transforming growth factor beta-activate kinase 
(tak1) gene  plays a critical role in JNK signaling during development and over-
expression of tak1 can induce premature cell death41,68.  Indeed, over-expression of a high 
level of tak1 or its direct target, the JNK kinase (JNKK) hemipterous (hep), efficiently 
induced premature neuroblast loss in the larval brain (Fig. 2.7L-O).  Similar to fzy5032 
mutant neuroblasts, neuroblasts with aberrant JNK activation often showed diminished 
expression of Dpn (Fig. 2.7M).  Co-expression of P35 failed to prevent premature loss of 
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neuroblasts induced by tak1 over-expression (Fig. 2.7O), suggesting that this death is 
caspase-independent.  Finally, expression of either a kinase dead form of Tak1 or an 
analogous JNKKK, Apoptotic signal-regulating kinase 1 (Ask1), were not able to induce 
premature neuroblast loss, arguing that the kinase signaling property is required for 
neuroblast death in aberrant JNK activation and that this process is specific to Tak1 
activation (Fig. 2.7O).  Together, these results led us to conclude that aberrant activation 
of JNK signaling through Tak1 contributes to necrotic cell death of neuroblasts in the 
fzy5032 mutant brain. 
 
Catastrophic genotoxic stress leads to necrosis in neuroblasts 
 Since Fzy, which is normally expressed in neuroblasts, is required to suppress 
necrosis in neuroblasts, we hypothesized that necrosis may be used to eliminate cells in 
pathological situations.  However, thus far we have demonstrated that energetic, 
oxidative, and protein stress are insufficient to induce neuroblast necrosis.  This led us to 
examine another major target of cellular damage: genotoxic stress.  Knockdown of 
subunits in the chaperonin containing Tcp-1 complex (CCT), CCT2 and CCT4, caused a 
significant loss of neuroblasts as well as the appearance of abnormal mitochondrial 
morphology, ROS, and ubiquitin-conjugated aggregates (Fig. 2.8A-C, G-I, M-O, Y-AA).  
Importantly, loss of CCT function led to loss of Fzy expression in neuroblasts, suggesting 
this complex functions upstream of Fzy in promoting neuroblast survival (Fig. 2.8S-X, 
BB).  The CCT complex plays a major role in folding structural proteins such as tubulin, 
which is required for proper centriole and spindle formation69,70.  Indeed, loss of CCT 
function caused decreased tubulin content in mitotic spindles (Fig. 2.9F-H).  This result 
suggests that perturbation of cell cycle processes by loss of CCT may be promoting 
neuroblast necrosis. 
 To test the impact of genotoxic stress further, we examined mutations in the core 
telomere capping complex, caravaggio (cav) and suppressor of variegated 205 
(Su(var)205), and of flap endonuclease-1 (fen1)71,72.  Each of these mutations faithfully 
recapitulated the loss of neuroblast phenotype as well as the appearance of necrosis 
markers (Fig. 2.8D-F, J-L, P-R, Y-AA).  Furthermore, they also caused loss of Fzy 
expression in the neuroblasts (Fig. 2.8V-X, BB).  Loss of telomere capping exposes 
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chromosomal ends which are treated as double strand breaks by DNA repair machinery.  
Similarly, loss of Fen1 function allows unresolved DNA flaps which are treated as 
lesions by the cell.  Accordingly, DNA damage as detected by the presence of 
phosphorylated histone H2A variant (pH2Av) was completely undetectable in wild-type 
neuroblasts but appeared in both telomere capping mutant neuroblasts and fen1 mutant 
neuroblasts (Fig. 2.9A-E).  Together, these data suggest that catastrophic damage to DNA 
or cell cycle machinery causes loss of Fzy expression and neuroblast necrosis. 
 
p53 up-regulation induces necrosis in neuroblasts 
 Both the disruption of spindle formation and DNA damage can cause dividing 
cells to trigger cell cycle arrest and possible death.  p53 transcription factor is a key 
regulator of cell cycle arrest and cell death in response to genotoxic stress in many 
dividing cells73,74.  Thus, we examined whether p53 plays a role in neuroblast death.  
Over-expression of wild-type p53 specifically in neuroblasts led to a significant decrease 
in neuroblast number as well as appearance of ROS and ubiquitin-conjugated aggregates 
(Fig. 2.10E-F, I-J, Q, S).  p53 up-regulation also caused loss of Fzy expression, 
suggesting that Fzy acts downstream of p53 in regulating necrosis (Fig. 2.10M-N, T).  A 
dominant-negative form of p53 did not present with loss of neuroblasts, necrosis marker 
expression, or loss of Fzy expression (Fig. 2.10C, G, K, O, Q-T).  Importantly, co-
expression of dominant-negative p53 with wild-type p53 resulted in a partial rescue of 
the loss of neuroblasts, ubiquitin-conjugated aggregates, appearance of ROS, and loss of 
Fzy expression phenotypes caused by wild-type p53 (Fig. 2.10H, L, P, Q, S-T).  
Curiously, mitochondrial morphology was not detectably altered by over-expression of 
wild-type p53 (Fig. 2.10A-B, R).  This may indicate that change in mitochondrial 
morphology depends on a stronger loss of Fzy function than that caused by p53 over-
expression.  These results suggest that increased p53 transcriptional regulatory activity 
induces loss of Fzy expression and neuroblast necrosis.  
 When activated by genotoxic stress, p53 can trigger cell cycle arrest in a context 
specific manner75.  We tested if p53-triggered cell cycle arrest caused neuroblast death.  
Wee1 is normally suppressed by Cdk1 (encoded by cdc2).  Activation of Wee1 causes 
cell cycle arrest at the G2 to M transition downstream of p53 activation. Consistently, 
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either over-expression of wee1 or knockdown of cdc2 caused a decreased frequency of 
neuroblasts with cytoplasmic Dpn localization (Fig. 2.11A-D).  Since Dpn is a nuclear 
transcription factor, the percentage of cells with cytoplasmic Dpn indicates the 
percentage of cells with nuclear envelope breakdown.  This served as a proxy 
measurement for the percentage of cells in mitosis, suggesting that over-expression of 
wee1 or loss of cdc2 did indeed cause cell cycle arrest.  Furthermore, both mutations 
caused enlargement of the neuroblasts, consistent with cells that are growing in 
preparation for cell division but unable to actually divide (Fig. 2.11A-C).  However, 
neither mutation was sufficient to cause loss of neuroblasts (Fig. 2.10Q).  These results 
demonstrate that cell cycle arrest downstream of p53 activation is not sufficient to induce 
neuroblast necrosis.  p53 over-expression likely acts through a parallel pathway to trigger 
neuroblast necrosis. 
 p53 activation of apoptosis is believed to be a potent tumor suppressing 
mechanism76.  Cancer depends on conditions which favor frequent mutagenesis.  
Removing cells that have acquired too many random mutations by programmed cell 
death is an efficient way to eliminate the threat posed by these cells.  To test if Fzy-
dependent neuroblast necrosis is capable of removing tumorigenic cells, we examined 
fzy5032 mutants in the brain tumor (brat) mutant genetic background.  brat mutant larvae 
are able to produce a large number of supernumerary neuroblasts and have served as a 
good model for studying tumorigenesis (Fig. 2.12A)77,78.  The fzy5032 mutation was able to 
completely suppress the neuroblast overproliferation phenotype in a strong brat mutant 
background (Fig. 2.12B-C).  These results suggest that the Fzy-dependent cell death 
mechanism functions downstream of the brat phenotype and that a p53-dependent 
necrotic cell death would be capable of killing brat mutant neuroblasts. 
  
39 
 
Discussion 
We report here the discovery of a novel mechanism that is dedicated to 
maintaining stem cell survival and not involved in determining stem cell identity.  We 
have demonstrated that the APC/C-Fzy complex mediates the survival of Drosophila 
larval neuroblasts independently of its role in promoting cell proliferation.  Mutations 
that occur in the surfaces of the Fzy/Cdc20 WD40 repeats not required for the binding of 
Fzy to mitotic regulatory proteins, specifically lead to premature neuroblast cell death.  
Furthermore, we have found that catastrophic genotoxic stress on the neuroblasts causes 
them to undergo necrosis and display the same morphological markers as Fzy loss of 
function mutants.  Meanwhile, p53 up-regulation produced the same effect, arguing that 
cellular damage and the coping mechanisms for damage may utilize this necrosis 
mechanism to mediate cell survival.  
We propose that APC/C-Fzy promotes neuroblast proliferation while also 
surveilling the neuroblast pool by selectively targeting distinct substrates for ubiquitin-
dependent protein degradation (Fig. 2.12D).  In wild type neuroblasts, an uncharacterized 
necrosis activator(s) is recruited to the APC/C-Fzy complex to be ubiquitinated.  Routine 
degradation of this factor ensures survival of neuroblasts.  In fzy5032 mutant neuroblasts, 
this activator is unable to be recruited by Fzy because of the specific lesion in the WD40 
repeats, despite Fzy5032 still being able to activate APC/C ubiquitantion activity and 
promote cell cycle progression.  The perdurance of this factor leads to activation of JNK 
signaling and Aif pathways, which ultimately contribute to neuroblast necrosis.  
Discovering the necrosis activator directly targeted by APC/C-Fzy will be crucial to 
substantiate this model.  It is possible that multiple factors which can promote cell death 
are suppressed by APC/C-Fzy in this manner. 
Accumulating evidence indicates that Fzy/Cdc20 functions to regulate many 
cellular processes in addition to their well-established role in promoting cell proliferation 
via an APC/C complex-dependent mechanism17,18.  For example, loss of Cdc20 in 
cerebellar slices has been shown to reduce synaptic cluster density by stabilizing 
NeuroD2 in a mechanism similar to the one we propose18.  Cdc20 also regulates the 
degradation of Id1 during dendrite growth17.  Most importantly, Cdc20/Fzy executes 
these functions by recruiting novel substrates to the APC/C complex for ubiquitin-
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dependent protein degradation.  The best-characterized degradation motifs that bind to 
APC/C-Cdc20 are the KEN- and D-box motifs49.  Indeed, both the NeuroD2 and Id1 
proteins contain motifs that are highly similar to the canonical D-box, but it is currently 
unknown whether the degradation motif from NeuroD2 and Id1 binds to Cdc20/Fzy 
through the same surfaces on the WD40 repeats that mitotic cyclins bind to, or different 
surfaces.  Since this diversity in substrate binding appears unlikely to be caused by 
allosteric changes in APC/C conformation upon co-activator binding13, one attractive 
possibility is that distinct surfaces on the WD40 repeats of Cdc20/Fzy might recognize 
distinct categories of substrates.  Our work indicates that the WD40 repeats containing 
the fzy5032 and fzyAC-10 mutations are required for binding novel substrates of APC/C-Fzy 
which mediate neuroblast survival.  More thorough characterization of the Fzy binding 
surfaces that are required to maintain neuroblast survival will provide critical insight 
toward understanding how the APC/C complex regulates diverse biological processes. 
Since the fly genome appears to lack orthologs of RIP kinases, this raises 
important questions about the regulation of necrotic cell death in Drosophila.  One 
possible mechanism is that downstream TNF signaling triggers a form of non-apoptotic 
cell death with similar properties to mammalian programmed necrosis67.  Another 
possibility might be that JNK signaling leads to increased oxidative stress upon 
activation64,65.  Removing the function of TNF had no effect on premature loss of 
neuroblasts in fzy mutant brains whereas removal of JNK significantly prolonged the 
survival of fzy mutant neuroblasts.  Furthermore, ectopic JNK signaling in neuroblasts 
caused by over-expression of a JNKKK or JNKK killed them in a manner similar to 
fzy5032 mutation.  Thus, we propose that APC/C-Fzy prevents neuroblast necrotic cell 
death in part by antagonizing the activation of JNK signaling.  Curiously, loss of tak1 did 
not rescue the neuroblast death phenotype in fzy5032 mutants (data not presented).  
However, there are at least 5 fly orthologs of JNKKK with some partially overlapping 
functions79.  While over-expression of one of these orthologs, Ask1, did not lead to loss 
of neuroblasts, it is possible that other JNKKK orthologs can contribute.  Therefore, it is 
likely that loss of a single JNKKK would have no phenotype.  Indeed, the tak1 null 
mutant animals are perfectly viable and fertile.  Consistent with this hypothesis, loss of 
another JNKKK, Wallenda, also did not rescue neuroblasts from death in fzy5032 mutants 
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(data not presented).  Additional experiments will be necessary to determine the 
mechanism by which APC/C-Fzy suppresses activation of JNK signaling. 
Aif has emerged as a tantalizing candidate for executing non-apoptotic cell 
death63,80.  Aif is a mitochondrial protein and becomes released following an increase in 
ROS and calcium ions.  The soluble Aif can then translocate to the nucleus where it may 
activate DNA fragmentation and cell death.  While fzy5032 mutant neuroblasts displayed 
an increase in ROS production and cytosolic calcium ion, increased ROS production 
alone seemed to be insufficient for triggering neuroblast necrosis.  These data are 
consistent with ROS simply facilitating the release of Aif following onset of necrotic cell 
death.  Similarly, mitochondria defects alone were insufficient to induce neuroblast death.  
In contrast, cytosolic calcium ion activates Calpain I to cleave the full-length Aif and 
release it from mitochondria.  Since the fly proteins CalpA and CalpB share homology 
with Calpain I, these two proteases are excellent candidate proteins that likely are 
involved in the activation of neuroblast necrotic cell death in fzy mutant brains.  
Functional assessment of the roles of CalpA and CalpB in neuroblast necrotic cell death 
will be critical in the future to test this hypothesis. 
The biological significance of a Fzy-mediated necrosis mechanism appears to be 
linked to the health of the cell.  Thus, this mechanism may present a novel cell 
checkpoint which monitors the neuroblast for damage, and translates irreparable damage 
into cell death.  Neuroblasts appear to be able to sustain certain damage, such as 
increased ROS production or ubiquitin-conjugated aggregates, without triggering death.  
However, catastrophic genotoxic stress was able to induce neuroblast necrosis.  
Interestingly, p53 over-expression produced a similar phenotype, suggesting that it may 
function to translate the cell damage into a cell death response.  This would be consistent 
with its known role as a genomic stability checkpoint master regulator.  The ability of 
p53 to induce necrosis seems to be distinct from its ability to arrest the cell cycle, since 
over-expression of factors that induce cell cycle arrest downstream of p53 activation did 
not cause loss of neuroblasts.  In the literature, p53 is most commonly described as a 
regulator of apoptosis.  However, the exact mode of cell death caused by p53 is 
frequently not characterized in detail and overlapping death mechanisms may exist.  The 
apoptosis pathway in fly larval neuroblasts is epigenetically repressed before pupation.  
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Thus, even if pro-apoptotic signals exist in neuroblasts, they would unlikely be able to 
trigger apoptosis.  This study suggests that a novel programmed necrosis mechanism may 
exist is neuroblasts as a backup to trigger cell death in the absence of apoptosis. This 
pathway is responsive to cell damage and p53 activation, very similarly to how apoptosis 
may act in such a context. 
Our study discovered a previously unknown function of Fzy in maintaining stem 
cell viability by suppressing necrotic cell death exclusively in the brain.  Mechanistic 
insight into how Fzy maintains the viability of neural stem cells by antagonizing necrotic 
cell death might lead to novel strategies to selectively attenuate the pro-survival function 
of Fzy in cells possessing stem cell characteristics in the brain.  Brain tumor stem cells 
possess similar functional properties as normal neural stem cells, except they proliferate 
more rapidly81–83.  Thus, brain tumor stem cells are likely more dependent on Fzy and 
thus more sensitive to manipulations that perturb Fzy function.  As such, selectively 
inactivating the pro-survival function of Fzy might preferentially target brain tumor stem 
cells while sparing normal neural stem cells and stem cells in other organs.  Further 
investigation into whether Cdc20 is required for maintaining specific stem cell 
populations in mammals is required.  These strategies will likely improve the efficiency 
of cancer therapies while reducing unwanted side effects. 
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Figure 2.1. The fzy5032 mutation specifically attenuates the function of fzy in 
maintaining neuroblasts and does not perturb Fzy promoting cell proliferation.  
(A-F) Larval brains of the genotypes indicated were stained for the neuroblast marker 
Deadpan (Dpn) and Miranda (Mira) and the cortex marker Phalloidin (Phall). Brains 
were dissected from larvae aged for 48 (A-C) or 72 (D-F) hours after larval hatching 
(ALH). Arrows mark neuroblasts and dotted lines mark optic lobes. Scale bars, 20µm.  
(G) Average number of Dpn+ neuroblasts per larval brain lobe in the genotypes indicated 
during larval development (N = 10 brain lobes per genotype, error bars here and in all 
future graphs represent mean ± S.D).  
(H, I) Dorsal view of pharate adult brains from control or fzy mutant pupae aged for 120 
hours APF. Scale bar, 1mm. 
(J, K) Horizontal sections of control and fzy mutant pupae brains at 96 hours after pupae 
formation (APF) visualized with hematoxylin and eosin. Scale bar, 200µm. 
(L-R) GFP-marked central brain neuroblast mosaic clones of the genotypes indicated 
were stained for Dpn, GFP, and Prospero (Pros), a marker for immature neurons. Clones 
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were induced at 24 hours ALH and examined at 96 hours ALH. Arrows mark mother 
neuroblasts. Dotted lines mark clones. Scale bar, 10µm. 
 (S-Y) GFP-marked optic lobe neuroepthelial cell mosaic clones of the genotypes 
indicated were stained for Dpn, GFP and Pros. Clones were induced at 24 hours ALH and 
examined at 96 hours ALH. Dotted lines mark clones. Scale bar, 10µm.  
(Z) Quantification of percentage of central brain neuroblast clones containing more than 
2 cells versus percentage containing 2 or fewer cells for each genotype. Cell count 
includes mother neuroblast. Star indicates p-value < 0.001 as determined by chi-square 
test. All future stars will indicate p<0.001 for the marked genotype in comparison to the 
control or wild-type genotype in the same graph. 
(AA) Quantification of percentage of optic lobe neuroepithelial clones containing more 
than 2 cells versus percentage containing 2 or fewer cells for each genotype. 
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Figure 2.2. Fzy point mutations in the WD40 repeats specifically ablate neuroblast 
maintenance but allow cell cycle progression. 
(A) Average number of Dpn+ neuroblasts per brain lobe in the genotypes indicated at 96 
hours ALH. The fzy genomic transgene is abbreviated as fzy(g). fzy5032 indicates fzy5032 
homozygous (this and all similar graphs represent mean ± S.D.).  
(B) The molecular lesions induced by the fzy5032 or fzyAC-10 mutation.  
(C) The relative expression level of fzy mRNA to rp49 mRNA in control or fzy mutant 
larvae (N = 3 reactions per genotype).  
(D-E) Larval brains of the genotypes indicated at 96 hours ALH stained for Fzy and 
Phall. Arrows mark neuroblasts. Dotted lines mark optic lobe. Scale bar, 20µm.  
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(F-G) Photograph of pharate adult head of the indicated genotypes. Arrows mark 
macrochaetes or large bristles that were counted. 12 stereotypical bristles were counted 
on each wild type head and the analogous bristles, if present were counted on mutant 
heads. 
(H) Quantification of bristles per head on control versus fzy5032 mutant pharate adult 
heads. 
(I-K) GFP-marked mosaic clones derived from wing imaginal disc cells of the genotypes 
indicated were stained for Dpn and GFP. Dotted lines mark clones. Scale bar, 40µm. 
All larval clones were induced at 24 hours ALH and examined at 96 hours ALH. 
(L-N) GFP-marked mosaic clones of adult midgut stem cells derived of the genotypes 
indicated were stained for GFP, Pros and DNA. Clones were induced at 3 days post-
eclosion and examined 10 days post-eclosion. Yellow arrows mark enterocytes, 
identifiable by their large 8n nuclei. White arrows mark enteroendocrine cells, 
identifiable by anti-Pros antibody. Unmarked cells in clones are likely stem cells or 
progenitors 84. Dotted lines mark clones. Scale bar, 20µm. 
(O) Protein sequence alignment of CDC20 between five species: D. melanogaster, H. 
sapiens, M. musculus, S. cerevisiae, and S. pombe. Only β propellers 3 and 6 of the 
WD40 repeats are shown. Numbering marks Drosophila Fzy residue position. Red boxes 
mark residues mutated in fzy5032 and fzyAC-10 mutants.  
(P) Quantification of total wild-type versus fzy mutant clones per lobe. Total clones 
include all clones containing at least 3 cells, with or without a mother neuroblast. 
(Q) Percentages of clones which were missing the mother neuroblast among wild-type 
versus fzy mutant clones. Only clones containing at least three cells were counted. Small 
percentages of wild-type clones missing neuroblast were likely derived from intermediate 
neural progenitors.   
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Figure 2.3. Premature loss of neuroblasts in fzy mutant brains unlikely occurs as a 
consequence of mitotic catastrophe.  
(A) The structure of the WD40 repeats of S. pombe Slp1 protein. The analogous residues 
to those mutated in Fzy5032 (pink) and FzyAC-10 (cyan) are marked, as determined by 
sequence alignment between Slp1 and Fzy. D box-binding (green) and KEN box binding 
(purple) residues are marked.  
(B-D) Wild type brains at 96 hours ALH stained for indicated markers. 
(E-G) Larval brains at 96 hours ALH from animals expressing non-degradable Cyclin B 
(CycBs) under the control of a heat-shock promoter. 
(H-J) fzy mutant brains at 96 hours ALH. 
In B, E, and H, yellow arrows mark Dpn+ neuroblasts and white arrows mark Dpn- dying 
neuroblasts. Elav marks differentiating neurons. Scale bar, 40µm. 
In C, F, and I, arrows mark nuclei. Lamin (Lam) marks nuclear envelope. DNA 
visualized by Hoechst. Scale bar, 20µm. 
In D, G, and J, arrows mark neuroblasts. Scale bar, 40µm. 
All dotted lines mark optic lobes. 
(K) Average number of Dpn+ neuroblasts per brain lobe in the genotypes indicated at 96 
hours ALH. Expression of the non-degradable CyclinA (CycA∆170) transgenic protein 
was driven by a neuroblast-specific Wor-Gal4 driver.  
49 
 
 
Figure 2.4. fzy mutant neuroblasts undergo necrotic cell death.  
(A) Average number of Dpn+ neuroblasts per brain lobe in the genotypes indicated at 96 
hours ALH. ark dronc and dredd encode proteins required for apoptosis. atg1 and atg7 
encode proteins required for autophagy.  
(B-C) Transmission electron micrographs of neuroblasts in the genotypes indicated at 96 
hours ALH. B’, C’ are higher magnifications of areas marked by yellow boxes in B, C. 
Red stars mark mitochondria. Scale bars, 500nm. 
(D-E) Neuroblasts in larval brains of the genotypes indicated at 72 hours ALH were 
stained for ATP5a (complex V of mitochondria ATP synthase), Phall and Dpn. Yellow 
arrow marks neuroblast with no mitochondrial aggregates. White arrow marks neuroblast 
with aggregates. Scale bar, 10µm.  
(F) Quantification of Dpn+ neuroblasts with evenly interspersed mitochondria (green) 
versus compacted or aggregated mitochondria (blue) in larval brains of the genotypes 
indicated at 72 hours ALH. 
(G-H) Unfixed larval brains of the genotypes indicated at 96 hours ALH stained with 
dihydroethidium (DHE), a small molecule whose signal indicates presence of superoxide 
free radicals61. Yellow arrows mark neuroblasts which were identifited by expression of 
PCNA::3XEmGFP and had low or no detectable ROS. White arrows mark neuroblasts 
with high ROS. Dotted lines mark optic lobes. Scale bar, 40µm.  
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(I) Quantification of PCNA::3XEmGFP+ neuroblasts with high levels of ROS (green) 
versus low levels of ROS (blue) in larval brains of the genotype indicated at 96 hours 
ALH. 
(J-K) Larval brains of the genotypes indicated at 72 hours ALH were stained for GFP, 
Phall and Dpn. The levels of calcium ion were assessed by expression of the GCaMP3.0 
transgenic protein driven by Wor-Gal4, indicated by the GFP activity. Yellow arrows 
mark Dpn+ neuroblasts with low or no calcium. White arrows mark neuroblasts with high 
calcium. Dotted lines mark optic lobes. Scale bar, 40µm.  
(L) Quantification of neuroblasts with low calcium (green) or high calcium (blue) based 
on GCaMP3.0 signal in larval brains of the genotype indicated at 72 hours ALH. 
(M-N) Neuroblasts in larval brains of the genotypes indicated at 72 hours ALH stained 
for ubiquitin-conjugated species (antibody FK2), Dpn, and Phall. Yellow arrow marks 
neuroblast with no aggregates. White arrow marks neuroblast with aggregates. Scale bar, 
10µm. 
(O) Quantification of neuroblasts with (blue) or without (green) ubiquitin-conjugated 
aggregates in larval brains of indicated genotypes at 72 hours ALH.  
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Figure 2.5. Loss of APC function leads to neuroblast necrosis. 
(A) Summary diagram of the APC/C-Fzy complex). Scaffold subunits (green); catalytic 
subunits (orange); substrate recruitment subunits (blue). Crosshatches mark subunits 
whose mutants were analyzed. 
(B-G) Larval brains of control and APC/C subunit mutants at 96h ALH stained for Dpn 
and Phall. Arrows mark Dpn+ neuroblasts. Scale bar, 40µm. 
(H-M) Neuroblasts in larval brains of control and APC/C mutants at 96h ALH stained for 
ATP5a, Dpn and Phall. Yellow arrow marks neuroblast with no mitochondrial 
aggregates. White arrows mark neuroblasts with aggregates. Scale bar, 10µm. 
(N-S) Unfixed larval brains of APC/C mutants at 96h ALH stained for DHE. Yellow 
arrows mark neuroblasts with low or no detectable ROS. White arrows mark neuroblasts 
with high ROS. Scale bar, 40µm. 
(T-Y) Larval brains of control and APC/C subunit mutants over-expressing GCaMP3.0 at 
96h ALH stained for GFP, Dpn and Phall. Yellow arrows mark Dpn+ neuroblasts with 
low or no detectable calcium. White arrows mark Dpn+ neuroblasts with high calcium. 
Scale bar, 40µm. 
(Z) Average number of Dpn+ neuroblasts per brain lobe in the apc mutants.  
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Figure 2.6. Necrosis markers are not sufficient to induce neuroblast necrosis. 
(A-C) Unfixed larval brains of the genotypes indicated were stained with DHE. Wild 
type and pink1 mutant animals were raised at 25°C and sacrificed at 96 hours ALH. 
Wor>ND42RNAi animals were raised at 33°C and sacrificed at 72 hours ALH. All RNAi 
knockdown animals in this study co-expressed dcr2. Yellow arrows mark neuroblasts 
with low or no detectable ROS. White arrows mark neuroblasts with high ROS . Scale 
bar, 40µm. 
(D) Quantification of neuroblasts in brains of indicated mutants. pink1 mutant animals 
were raised at 25°C and sacrificed at 96 hours ALH. All others were raised at 33°C and 
sacrificed at 72 hours ALH. 
(E-H) Neuroblasts in brains of larvae of indicated genotypes at 72h ALH stained for 
ubiquitin-conjugated aggregates, Dpn, and Phall. Yellow arrows mark neuroblasts with 
no aggregates. White arrows mark neuroblasts with aggregates. Scale bar, 10µm. 
(I ) Quantification of neuroblasts with (blue) or without (green) ubiquitin-conjugated 
aggregates in indicated genotypes.  
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Figure 2.7. Fzy prevents neuroblast necrotic cell death through Aif and JNK 
dependent mechanisms. 
(A-D) GFP-marked mosaic clones derived from neuroblasts of the genotypes indicated 
were stained for Dpn, GFP and Pros. Dotted lines mark clones. Scale bar, 10µm. 
(E) Average number of cells per mosaic clone of the genotypes indicated. All clones with 
a single Dpn+ neuroblast were counted. 
(F-G) Neuroblasts in larval brains of indicated genotypes at 72h ALH stained for p-JNK, 
Dpn and Phall. Scale bar, 10µm. 
(H) Quantification of p-JNK+ (blue) versus p-JNK- (green) neuroblasts in brains of 
indicated genotypes. 
(I-J) GFP-marked mosaic clones derived from neuroblasts of the genotypes indicated 
were stained for Dpn, GFP and Pros. Dotted lines mark clones. Scale bar, 10µm. 
(K) Average number of cells per mosaic clone of the genotypes indicated. All clones with 
a single Dpn+ neuroblast were counted. 
(L-N) Larval brains over-expressing tak1 or constitutively active hep weakly (25°C) or 
strongly (33°C) stained for Dpn and Phall. Animals were sacrificed at 72 hours ALH. 
White arrows mark Dpn+ neuroblasts. Yellow arrows mark Dpn- dying neuroblasts. Scale 
bar, 40µm. 
(O) Quantification of neuroblasts in larval brains over-expressing the indicated 
transgenes. Animals were sacrificed at 72h ALH.  
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Figure 2.8. Catastrophic genotoxic stress causes loss of Fzy expression and 
neuroblast necrosis. 
(A-F) Neuroblasts in larval brains of the indicated genotypes stained for ATP5a, Dpn and 
Phall. Yellow arrow marks neuroblast with no mitochondrial aggregates. White arrows 
mark neuroblasts with aggregates. Scale bar, 10µm. 
(G-L) Unfixed larval brains of the indicated genotypes stained for DHE. Yellow arrows 
mark neuroblasts with low or no detectable ROS. White arrows mark neuroblasts with 
high ROS. Scale bar, 20µm. 
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(M-R) Neuroblasts in larval brains of the indicated genotypes stained for ubiquitin-
conjugated aggregates, Dpn and Phall. Yellow arrows mark neuroblasts with no 
aggregates. White arrows mark neuroblasts with aggregates. Scale bar, 10µm. 
(S-X) Neuroblasts in larval brains of the indicated genotypes stained for Fzy, Dpn and 
Phall. Yellow arrows mark Dpn+ neuroblasts with Fzy. White arrows mark Dpn+ 
neuroblasts with no detectable Fzy. Scale bar, 10µm. 
(Y) Quantification of neuroblasts in larval brains of the indicated genotypes. 
(Z) Quantification of neuroblasts with interspersed (green) or aggregated (blue) 
mitochondrial morphology in larval brains of the indicated genotypes. 
(AA) Quantification of neuroblasts with (blue) or without (green) ubiquitin-conjugated 
aggregates in larval brains of indicated genotypes. 
(BB) Quantification of neuroblasts with (green) or without (blue) Fzy expression in larval 
brains of indicated genotypes.  
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Figure 2.9. Loss of telomere capping or chaperonin function lead to DNA or cell 
cycle damage. 
(A-D) Larval brains of indicated genotypes stained for DNA damage marker 
phosphorylated histone H2Av, Dpn and Phall. Yellow arrows mark Dpn+ neuroblasts 
with no detectable DNA damage. White arrows mark neuroblasts with DNA damage. 
Scale bar, 40µm. 
(E) Quantification of neuroblasts with (blue) or without (green) phopho-H2Av marker in 
larval brains of the indicated genotypes. 
(F-H) Representative images of metaphase neuroblasts in larval brains of the indicated 
genotypes at 72h ALH. Stained for alpha-Tubulin which marks the mitotic spindle, Dpn 
and Phall. Scale bar, 10µm.  
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Figure 2.10. Up-regulation of p53 causes loss of Fzy expression and neuroblast 
necrosis. 
(A-D) Neuroblasts in larval brains of the indicated genotypes stained for ATP5a, Dpn and 
Phall. Yellow arrows mark neuroblasts with no detectable mitochondrial aggregates. 
Scale bar, 10µm. 
(E-H) Unfixed larval brains of the indicated genotypes stained for DHE. Yellow arrows 
mark neuroblasts with low or no detectable ROS. White arrows mark neuroblasts with 
high ROS. Scale bar, 20µm. 
(I-L) Neuroblasts in larval brains of the indicated genotypes stained for ubiquitin-
conjugated aggregates, Dpn and Phall. Yellow arrows mark neuroblasts with no 
aggregates. White arrows mark neuroblasts with aggregates. Scale bar, 10µm. 
(M-P) Neuroblasts in larval brains of the indicated genotypes stained for Fzy, Dpn and 
Phall. White arrows mark neuroblasts with Fzy expression. Yellow arrows mark 
neuroblasts with low or no detectable Fzy. Scale bar, 10µm. 
(Q) Quantification of neuroblasts in larval brains of the indicated genotypes. 
(R) Quantification of neuroblasts with interspersed (green) or aggregated (blue) 
mitochondrial morphology in larval brains of the indicated genotypes.  
(S) Quantification of neuroblasts with (blue) or without (green) ubiquitin-conjugated 
aggregates in larval brains of indicated genotypes. 
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(T) Quantification of neuroblasts with (green) or without (blue) Fzy expression in larval 
brains of indicated genotypes. 
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Figure 2.11. p53-mediated cell cycle arrest does not cause cell death. 
(A-C) Larval brains of indicated genotypes stained for Dpn and Phall. Yellow arrows 
mark Dpn+ neuroblasts with cytoplasmic Dpn localization. White arrows mark 
neuroblasts that display nuclear Dpn localization. Scale bar, 20µm. 
(D) Quantification of percentage of neuroblasts in indicated genotypes with cytoplasm 
localized Dpn. 
(E) Quantification of percentage of neuroblasts in indicated genotypes with Fzy 
expression (green) versus without Fzy expression (blue). 
(F-H) Nuroblasts in larval brains of indicated genotypes stained for Fzy, Dpn, and Phall. 
Yellow arrows mark neuroblasts with wild-type Fzy expression. Scale bar, 10µm.  
F G H 
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Figure 2.12. Fzy-mediated necrosis kills tumorigenic neuroblasts. 
(A) Larval brain of brat mutant at 96h ALH demonstrating strong supernumerary 
neuroblast phenotype.  Optic lobe is largely displaced by Dpn+ central brain neuroblasts.  
Scale bar, 40µm. 
(B) Larval brain of fzy5032 mutant in brat mutant background at 96h ALH.    
(C) Larval brain of fzy null mutant in brat mutant background, with one copy of wild type 
fzy genomic transgene at 96h ALH. 
 (D) Model of how Fzy maintains neuroblast viability. Wild-type Fzy (blue) is able to 
activate APC (green) and recruit endogenous substrates for ubiquitination (red), including 
the presumed immediate downstream factor(s) required for activating necrotic cell death 
(purple). Fzy5032 (pink) is not able to recruit the necrotic cell death activator(s), leading to 
perdurance of the factor and eventually necrotic cell death of the neuroblast.
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CHAPTER 3 
FUTURE DIRECTIONS AND PERSPECTIVES 
 
 
Downstream Mechanisms 
 
The identification of fzy as a neuroblast maintenance gene has provided a starting 
point for uncovering the nature of cell death occurring in fzy5032 mutant neuroblasts.  We 
know that the terminal morphology closely resembles necrotic cell death.  We also 
identified several markers which are consistent with necrosis, namely increased 
intracellular calcium, increased reactive oxygen species (ROS), and altered mitochondrial 
morphology (Fig 3.1).  These markers which serve as signs indicating that necrosis is 
occurring may also give clues as to what the terminal mechanisms of killing are. 
The appearance of superoxide species as detected by DHE is has been a consistent 
indicator of neuroblast necrosis.  In mammalian models of death receptor mediated 
necrosis, ROS are often produced and believed to be important for killing.  In many cell 
death studies, ROS have been implicated as possible agents of cell death simply by 
oxidizing nonspecific cellular targets and inducing massive damage.  ROS are also 
believed to trigger downstream signaling pathways or other mechanisms in certain 
contexts1.  ROS have been implicated in nonapoptotic cell death after ischemia-
reperfusion injury.  Experiments in primary chick cardiomyocyte cultures suggested that 
ROS production after ischemia promoted the opening of the mitochondrial permeability 
transition pore (mPTP), leading to loss of mitochondrial integrity and necrotic cell death2.  
Thus, there are multiple options for what ROS may be doing, if anything, in neuroblast 
necrosis.  However, current data suggests that ROS production alone is not sufficient to 
induce any sort of neuroblast loss.  This would argue against the model that suggests 
ROS triggers a mitochondrial alteration or signaling pathway to kill neuroblasts.  There is 
68 
 
still the possibility that ROS are contributing to the damage in the terminal stages 
of necrosis.  It remains to be seen if reduction in ROS production by over-expressing 
transgenes encoding ROS scavengers will attenuate the loss of neuroblasts in fzy mutant 
brains. 
The production of ROS is closely tied to mitochondrial health, since the primary 
source of ROS is leakage from the electron transport chain.  Thus it is not surprising that 
dying neuroblasts showed increased ROS as well as altered mitochondrial morphology.  
In fact, in cardiac ischemia-reperfusion injury studies, the opening of the mPTP caused 
by overload of calcium and ROS is thought to trigger necrosis3,4.  This would 
conveniently account for several of the markers seen in fzy mutant neuroblasts.   
One possibility is that loss of mitochondrial function is leading to energy 
depletion and death.  However, loss of Pten-induced kinase 1 (Pink1), which has been 
shown to be required for assembling the oxidative phosphorylation machinery in flies, 
did not result in any loss of neuroblasts5,6.  This suggests that simple metabolic deficiency 
is not the cause of neuroblast necrosis.  In various models of regulated necrosis, it is 
thought that release of mitochondrial factors contributes to cell death, much like release 
of cytochrome c in mammalian apoptosis7,8.  The questions, then, are what factors may be 
facilitating this release and what are the released products that then execute cell death?  It 
remains a possibility that calcium influx and ROS production function together induce 
mPTP opening in necrotic neuroblasts.  The peptidylprolyl-isomerase cyclophilin D 
(CypD) has been proposed to be a critical component of the mPTP.  Studies in mice and 
cell culture have shown that loss of CypD can attenuate apoptosis and necrosis, 
particularly in oxidative stress situations9–11.  There a few orthologs of the CypD in the 
Drosophila genome, all of which are poorly characterized.  It would be interesting to see 
if loss of CypD could modify the necrosis phenotype in fzy mutant animals. 
Acitvation of poly(ADP-ribose) polymerase 1 (PARP1) has been shown in 
mammals to lead to various forms of nonapoptotic cell death12–14.  PARP1 is normally a 
nuclear DNA repair protein which has the capability of responding to genotoxic stress.  
Various models of PARP1 activation suggest that PARP1 translocates to the 
mitochondria to trigger release of downstream factors that lead to necrosis.  One of the 
key mitochondrial proteins released by PARP1 activation is apoptosis-inducing factor 
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(AIF), which has been shown to trigger the terminal events of cell death12,15–17.  Loss of 
AIF partially rescued loss of neuroblasts in fzy mutant clones, suggesting that AIF may be 
functioning downstream of fzy to mediate necrosis.  It remains to be seen if PARP is 
acting as an intermediary in this mechanism.  AIF itself has been shown to coordinate 
large scale DNA fragmentation both in apoptosis and necrosis18–20.  Future experiments 
should help delineate the players involved in DNA degradation during neuroblast 
necrosis. 
A fascinating study recently demonstrated that p53 interacts with CypD to 
facilitate mPTP formation and cerebral necrosis in a mouse stroke model.   While loss of 
p53 did not appear to rescue the loss of neuroblast phenotype in fzy mutant brains, it is 
possible that the strong mutant background is not sensitive enough to detect modification 
by loss of p53.  It may be worthwhile to test if loss of p53 can rescue loss of neuroblasts 
in fzy mutant clones.  Another intriguing possibility is that mitochondrial fragmentation 
or fission is required for necrosis to occur.  This has been shown in recent work 
investigating the mitochondrial phosphatase PGAM5 in cell lines21,22.  In mammalian 
cells, PGAM5 organizes and facilitates the RIP1/RIP3 complex to phosphorylate and 
activate the mitochondrial fission protein Drp1.  Loss of Drp1 was able to attenuate 
programmed necrosis.  Demonstrating a role for PGAM5, Drp1, or mitochondrial 
fission/fusion in the neuroblast necrosis model would be significant. 
A topic that has not been touched upon in our studies thus far is the role of 
lysosomes and lysosomal proteins in cell death.  Lysosomal proteases and rupture of 
lysosomes have been shown to play critical roles in different forms of nonapoptotic cell 
death23.  Lockshin and Williams’ studies on silk moth muscle degradation found that an 
increase in cathepsin, a lysosomal protease, coincided with cell death24.  Proper 
acidification of lysosomes has been shown to be important for cell death in yeast and C. 
elegans models25–27.   Fly germ cell models have consistently reported that lysosome 
membrane permeabilization and release of lysosomal DNAse and proteases play integral 
roles in nonapoptotic cell death execution28,29.  Rupture of the lysosome can typically be 
detected with a probe that responds to cytosolic pH change.  The possible roles of 
lysosomal proton pumps, DNAses, and proteases should be tested in the appropriate fzy 
mutant background.  
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Removal of Necrotic Fragments 
 
The final fate of all cells programmed to die is typically engulfment by either 
professional phagocytes or neighboring non-professional phagocytes.  The mechanisms 
by which apoptotic bodies are taken up after death are relatively well characterized while 
phagocytosis of necrotic cell fragments is more poorly understood30–32.  Many of the 
advances in phagocytosis of necrotic cells have been made studying macrophage 
clearance of necrotic immune cells.  Some mechanisms for engulfment of cell corpses in 
Drosophila have come into focus recently as well.  The cell surface receptor Draper has 
been found to promote engulfment in multiple cell death contexts, including apoptosis, 
autophagy, and death following neuronal injury33–37.  In the adult Drosophila brain, a 
special subset of glia engulfs cell fragments after axonal injury38.  We hypothesize that 
cortical glia, which are in contact with and encase single neuroblasts and their lineage 
during larval development, may be responsible for engulfment of necrotic cell fragments 
in fzy mutant brains. 
There is currently little evidence for engulfment of necrotic neuroblasts.  A simple 
experiment could be done to determine if the neighboring glia truly are involved in 
phagocytosis.  Neuroblasts and glia may be marked in a cell specific manner with 
intracellular β-galactosidase and a membrane bound CD8-GFP, respectively.  These 
manipulations could be performed in a fzy mutant background and examination for β-
galactosidase localization within GFP+ cells would allow us to determine if necrotic cell 
fragments are being engulfed by glia.  Involvement of Draper or other candidate 
engulfment receptors could be analyzed genetically. 
While beyond the scope of this discussion, glial engulfment could potentially 
trigger extracellular signals to other tissues in the organism.  In mammals, this process 
can result in repair of damaged tissues nearby, but can also cause local or systemic 
inflammation.  Thus, the possible downstream functions of glia in managing neuroblast 
necrosis would be of great interest in future studies. 
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Fzy Substrate Specificity 
 
Using a homology model of Fzy based on the fission yeast Cdc20 crystal 
structure, we found that both fzy5032 and fzyAC-10 cause amino acid substitutions of 
residues far from the surfaces required for canonical Fzy function39.  This distance 
suggested that these mutations should not perturb the ability of Fzy to bind to its 
canonical mitotic substrates and perform its well-known function in promoting cell cycle 
progression.  Indeed, further studies showed that the Fzy5032 mutant protein is capable of 
promoting cell cycle progression but is not able to maintain neuroblasts.  Altogether, 
these led us to hypothesize that the fzy5032 and fzyAC-10 point mutations are located on 
uncharacterized surfaces of the WD40 protein binding domain of Fzy.  These surfaces are 
important for maintaining neuroblast viability.  Disruption of protein-protein interactions 
on these surfaces may lead to an inability of Fzy to recruit a substrate(s) for ubiquitin-
mediated degradation.  In turn, the increased level of this substrate leads to premature 
necrosis of neuroblasts. 
Targeted mutagenesis will be used to test this hypothesis (Appendix 1).  
Transgenic flies encoding fzy with point mutations located in the WD40 repeats will be 
generated.  These mutations will fall into one of two classes: mutations that are expected 
to disrupt canonical fzy function as a cell cycle regulator and mutations that are expected 
to disrupt fzy function in preventing necrosis.  Of the first class, two mutations will 
disrupt the KEN-box and one will disrupt the D-box binding surfaces.  These surfaces are 
reported to be required for fzy to bind to its canonical mitosis substrates39.  Five point 
mutations will disrupt the surface of the WD40 repeats near the mutated residue in fzy5032, 
while three point mutations will disrupt the WD40 repeats near the mutated residue in 
fzyAC10 (Fig 3.2).  The ability of these transgenes to rescue the fzy mutant phenotype will 
be examined.   
The likely outcome for the KEN-box and D-box mutant transgenes would be their 
inability to rescue cycle arrest in fzy null mutant cells, such as in wing imaginal disc 
clones or intestinal stem cell clones.  They may, however, still be able to rescue the 
neuroblast necrosis phenotype, either in a fzy5032 mutant background or in fzy5032 mutant 
neuroblast clones.  This would suggest that the D-box and KEN-box binding surfaces are 
72 
 
functionally distinct from the neuroblast maintenance surfaces.  Another likely possibility 
is that the KEN-box and D-box mutant transgenes will only partially rescue the 
neuroblast necrosis phenotype, which would suggest some shared interaction between the 
canonical surfaces and the new surfaces. 
The ability of the new transgenes, which have mutated residues near the Fzy5032 
and FzyAC-10 lesions, to modify the cell cycle or necrosis phenotypes will be much less 
predicatable.  We initially thought that fzy5032 was nearly wild type in promoting cell 
cycle progression.  However, recent experiments in wing imaginal disc clones suggested 
that fzy5032 may be slightly deficient in cell cycle promotion.  Over-expression of fzy5032 
was able to rescue the cell cycle arrest phenotype of fzy null wing imaginal disc clones, 
but the clones were still smaller than those rescued by wild type fzy over-expression (data 
not presented).  Thus, it is likely that both fzy5032 and fzyAC-10 cause minor defects in 
canonical fzy function.  However, their ability to maintain neuroblasts is very severely 
compromised, while their ability to promote the cell cycle remains largely intact.  The 
new transgenes might therefore not be able to rescue the necrosis phenotype in fzy5032 
neuroblasts, and they might also have cell cycle defects in fzy null neuroblasts.  The 
extent to which the transgenes rescue each phenotype would help us begin to map out the 
interaction surface of Fzy WD40 repeats in greater detail.  Finally, if the direct targets of 
Fzy are discovered in the future, the nature of their interactions with the WD40 repeats 
may be tested using targeted mutagenesis.  
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The Search for the Necrosis Activator 
 
 The current model of how loss of Fzy activates necrosis suggests that there must 
be a downstream target of Fzy, or perhaps multiple targets, which is normally 
phosphorylated by APC/C-Fzy and degraded.  Thus, this necrosis activator does not 
function to kill in the presence of intact Fzy but can build up to lethal levels in fzy mutant 
backgrounds.  No likely candidates for such a factor have been found in the literature yet, 
prompting us to employ unbiased approaches. 
 The most direct approach would be to attempt to immunoprecipitate Fzy protein 
with these potential factors bound, then dissociate and perform mass spectrometry to 
identify them.  The only tissue that would suffice for this experiment is larval brain.  The 
fzy mutant necrosis phenotype appears to be incredibly context dependent, since only the 
neuroblasts have shown to exhibit the phenotype thus far.  This likely depends on 
multiple factors, such as appropriate expression APC/C-Fzy, the potential targets, and 
proper modification and regulation of both.  However, using the larval brain as the source 
of material for a co-immunoprecipitation presents its own challenges.  There are only 100 
central brain neuroblasts in each brain lobe, which makes it tedious to collect a large 
enough sample for analysis, and potentially introduces non-specific binding due to the 
volume of brain taken up by other cell types.  Therefore, we propose to use a mutant 
background that will amplify the number of neuroblasts at the cost of other cell types.   
Mutation of the gene brain tumor (brat) was demonstrated to cause a 
dedifferentiation phenotype in a subset of neuroblasts40,41.  Loss of brat in an otherwise 
wild type background or with heterozygous loss of fzy led to a severe supernumerary 
neuroblast phenotype.  Importantly, fzy is required to maintain even the supernumerary 
neuroblasts, since the fzy5032 allele in a brat mutant background caused massive loss of 
neuroblasts.  In a fzy null, brat null double mutant brain, the presence of a single copy of 
a wild type fzy genomic fragment was able to completely restore the brat mediated 
supernumerary neuroblast phenotype.  These results suggest that it may be possible to 
express a tagged Fzy protein to rescue the fzy null phenotype in a brat mutant 
background.  This combination would presumably provide an enrichment of neuroblasts 
and give a tagged Fzy species with a stoichiometric advantage for co-
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immunoprecipitation experiments.  Future work will focus on obtaining a tagged Fzy 
transgene that is capable of rescuing the fzy mutant phenotype. 
 A genetic method for finding downstream factors is by using a dominant modifier 
screen.  The key to this method is to establish a sensitized genetic background that will 
allow for modification by haploinsufficient chromosomal deletions.  A library of fly 
chromosomal deletions, or deficiencies, can then be crossed into the background and the 
phenotype can be assessed.  Our lab has used this method in a brat mutant background to 
identify genes that interact with brat to regulate neuroblast self-renewal42.   
 We obtained a fzy mutant allele caused by an insertion of a transposable P-
element, called fzyEP1028 or simply fzyEP 43.  This allele was homozygous viable, unlike 
most other loss of function fzy alleles, suggesting that if it had a phenotype, it would be 
weak.  Indeed, fzy5032/EP transheterozygotes showed an intermediate loss of neuroblast 
phenotype compared to fzy5032/- animals (Fig 3.3A,D).  This phenotype was highly 
consistent across independent replicates.  Screening a library of Drosophila genome 
deficiencies covering a large portion of the 3rd chromosome has yielded several candidate 
loci which either suppress or enhance the sensitized phenotype (Fig 3.3A-C,E, Appendix 
2).  Importantly, most of these modifier loci overlapped with another modifier locus, 
suggesting that a gene in the overlap region was interacting with the fzy mutant 
phenotype and making it unlikely to due to a background mutation in the deficiency 
chromosome.  Some modifier loci or overlapping regions were small enough that single 
genes may be tested for their interaction with fzy (Fig 3.3F). 
 While the results of the screen thus far are encouraging, more work need to be 
done to analyze the genes within the identified modifier loci.  Further analysis will 
include experiments to examine the epistasis of the candidate genes with fzy and 
potentially each other.  This method does not guarantee that the genes found will function 
upstream or downstream, or that they will directly interact with fzy, only that they interact 
genentically.  In contrast, a co-immunoprecipitation is more likely to reveal the necrosis 
activator that may be functioning directly downstream of APC/C-Fzy.  
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Balancing Neuroblast Death versus Survival 
 
 The neuroblast has proven to be a unique system for investigation of cell death in 
response to injury.  Two interesting features are the ability of the neuroblasts to withstand 
cellular damage without arresting cell cycle or dying and the suppression of apoptosis.  
Both of these features may be related to the unusual circumstances of the neuroblast’s 
function.  Most of the larval neuroblasts are required to generate a vast number of cells 
without the benefit of transit amplification.  Each asymmetric division by a Type I 
neuroblast produces a differentiating cell that can only produce two final post-mitotic 
progeny.  Therefore, neuroblasts may prefer to divide as quickly as possible while 
ignoring any potential disruptions as long as possible. 
 A rough estimate based on the size of a typical mosaic clone of a larval neuroblast 
would put its cell cycle length at approximately 1.5 hours.  Wing imaginal disc cells, by 
comparison, have been reported to divide once every 8 hours44.  Similarly, the size of 
typical adult midgut stem cell clones would put their cell cycle time in the range of 12-16 
hours.  Neuroblasts are forced to divide so quickly because they divide asymmetrically, 
mostly without producing transit amplifying cells, and so can only generate one progeny 
per division.  Additionally, the short time window of larval development is when the 
neuroblasts must generalte almost all of the adult neural cells.  Therefore, a proper cell 
cycle checkpoint may not be as useful in a neuroblast as it would be in rare adult tissue 
specific stem cells.  Any neuroblast with its cell cycle blocked would be considered a 
useless neuroblast and fit for elimination, which is what happens in a developmentally 
timely fashion anyways. 
The need to ignore most types of cell damage might explain the ability of 
neuroblasts to tolerate high production of ROS, mitochondrial fusion defects, and excess 
ubiqitin-conjugated aggregates without dying.  It could be that none of these defects carry 
enough long term ramifications to the future progeny to warrant death of the neuroblasts.  
On the contrary, catastrophic loss of genomic integrity or defects in cell cycle progression 
directly threatens the production or survival of future progeny.  This may be why defects 
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in telomere capping and spindle assembly cause neuroblast death.  The preference to 
maintain neuroblasts’ unusually high proliferative rate may also explain the suppression 
of apoptosis by Polycomb group proteins45.  Apoptosis seems to be a common target for 
diverse pathways to integrate on in order to activate programmed cell death46.  This may 
actually work to the detriment of cells that are particularly valuable.  In the limited 
developmental time span during which neuroblasts need to continuously divide and avoid 
death, suppression of apoptosis in general forces to cell to stay alive and only die when a 
truly catastrophic event occurs. 
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A Stem Cell Health Checkpoint 
  
Neuroblast necrosis seems to be a response to either catastrophic DNA damage or 
cell cycle disruption.  This correlates with known functions of p53 as a master regulator 
of genomic integrity.  Without apoptosis available to kill these cells, necrosis is activated 
instead.  While p53 is commonly associated with either cell cycle arrest and DNA repair 
or apoptosis, it has also been found to activate cell death in a non-caspase dependent 
manner47.  The connection between p53 and Fzy is unprecendented, since Fzy has never 
been implicated in maintenance of cell viability.  However, Fzy may be well positioned 
to regulate necrosis in response to p53-mediated responses.  Fzy is already a key 
component of the cell cycle machinery and thus its expression or function may serve as a 
good monitor for how healthy the neuroblast cell cycle is.  Thus, p53 may simply be one 
of several pathways that converge on Fzy to trigger necrosis of the neuroblast. 
The telomere capping genes appeared to promote neuroblast maintenance and 
were highly expressed in neuroblasts compared to neural progeny48,49.  Loss of function 
mutations in both of these genes led to a loss of neuroblasts and similar marker 
expression as fzy mutant neuroblasts.  Aside from telomere fusions and a DNA damage 
response, uncapped telomeres in Drosophila could also trigger the spindle assembly 
checkpoint (SAC)50,51.  The SAC is normally activated during the metaphase to anaphase 
transition to prevent entry into anaphase until all kinetochores are anchored to 
microtubules.  One of the mechanisms by which this is accomplished is formation of the 
Mad protein complex at unanchored kinetochores and sequestration of Fzy/Cdc20 from 
binding to APC/C.  Without APC/C-Fzy activity, securin cannot be degraded and the 
kinetochores of the sister chromatids cannot separate52.  Loss of cav was found to trigger 
inappropriate SAC with Mad complex formation at the kinetochores as well as 
accumulation of the Mad protein BubR1 at the exposed telomeres50.  Interestingly, 
BubR1 is one of the Mad complex subunits which binds to Fzy in the SAC.  Thus, loss of 
telomere capping may be causing BubR1 and Fzy to accumulate at the telomere, 
effectively eliminating Fzy activity.  In this case, a partial loss of function of cav or 
Su(var)205 might presumably be rescued by overexpressing Fzy and bypassing the 
inappropriate SAC.  Furthermore, an independent mutation that would also be expected 
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to cause SAC activation should show a similar phenotype as neuroblast necrosis.  
However, over-expression of stabilized mitotic cyclins caused a metaphase arrest but was 
not able to mimic the neuroblast necrosis phenotype.  Therefore, it seems unlikely that 
SAC activation alone would trigger neuroblast necrosis.  Thus, the more likely cause for 
neuroblast death in telomere capping mutants is the DNA damage response. 
It is still unclear why necrosis in the fzy mutants occurs specifically in the 
neuroblast.  Curiously, despite most of the adult structures looking grossly normal in 
fzy5032 mutants, the bristle patterning appeared different.  fzy5032 mutant adults had far 
fewer bristles than control animals.  A Drosophila bristle originates from an epithelial 
cell which acquires a neural fate, and then undergoes a series of programmed asymmetric 
divisions to generate the four cells that make up each bristle organ53.  There are several 
possibilities for why these bristles may not have formed, including improper cell type 
specification or failure to execute the asymmetric divisions properly.  One way to 
interpret this is that somehow, only asymmetrically dividing progenitors of neural 
identity are affected by the fzy5032 mutation.  However, the actual thread linking these two 
cell types and segregating them from the other dividing cells might be the speed of cell 
division. 
We hypothesize that neuroblasts and perhaps other fast dividing cells may employ 
an altered cell cycle checkpoint which functions more like a cell health checkpoint.  Cells 
that have encountered too much damage, such as in telomere capping mutants or CCT 
mutants, would trigger this checkpoint mechanism.  An inability to progress through cell 
cycle in a timely manner will result in premature cell death, thereby eliminating the need 
to expend resources on that cell any further.  Thus, this checkpoint is designed to kill 
rather than repair.  Loss of fzy function would be acting as a downstream event in this 
checkpoint.  Thus, the fzy mutant neuroblasts are undergoing necrosis without any 
upstream trigger.  The telomere capping mutants and CCT mutants are likely activating 
intermediate mechanisms which eventually feed into loss of Fzy activity, activation of the 
checkpoint and death. 
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Final Remarks 
 
Cells that die due to defects in mitosis are typically believed to undergo mitotic 
catastrophe54.  This process has largely been studied and applied in cancer biology.  It is 
generally thought of as cell death occurring during or after aberrant mitosis, which can 
trigger cell death.  The Chk1 and Chk2 checkpoint regulators play particularly important 
roles in mitotic catastrophe.  Some cancers can evade these mechanisms, either by 
evading the cell cycle arrest and continuing to divide with DNA damage, or by blocking 
cell death and gaining the opportunity to divide again.  Initial morphological 
characterizations suggested that cells which suffered mitotic catastrophes may be 
triggered to die by apoptosis.  However, blockade of apoptotic machinery has been found 
to lead to increased loss of cells in some situations, suggesting that this mitotic 
catastrophe might lead to a specialized cell death pathway55,56.  The checkpoint that 
neuroblasts encounter may be a similar mechanism as mammalian mitotic catastrophe, in 
which irreparable damage to the cells leads to death.  One difference is that many 
example of mitotic catastrophe describe cells that have accumulated genomic instability 
after undergoing or attempting flawed mitoses, leading to aneuploidy and multinucleated 
cells.  This morphology was never observed in fzy mutant neuroblasts, suggesting that 
while the output may be the same, the mechanisms could be quite distinct. Further studies 
should determine if Chk1 and Chk2 checkpoint proteins as well as DNA damage 
response proteins such as ATM and ATR are activated prior to neuroblast death. 
Neuroblasts’ ability to withstand stress is another issue that requires elucidation.  
Sufficient genotoxic stress seems to trigger neuroblast necrosis.  What other forms of 
stress can lead to this phenotype?  In the literature, many different types of cellular injury 
have been associated with regulated cell death.  Some examples include ischemia-
reperfusion, protein stress or unfolded protein response, infection, and endoplasmic 
reticulum stress.  Many of these can be induced by genetic or pharmacological means.  It 
would be particularly interesting if protein aggregation in fly models of 
neurodegenerative disorders, such as Huntington’s, Amyotrophic lateral sclerosis, and 
Parkinson’s, led to the same necrotic cell death as in fzy mutant neuroblasts. 
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There are several features of neuroblasts that are somewhat reminiscent of cancer 
cells.  Neuroblasts divide relatively quickly, can avoid apoptosis even under extreme 
stress, and appear to have altered checkpoint mechanisms.  Neuroblasts seem to be 
resistant to quite a few stresses, such as increased ROS and mitochondrial dysfunction.  
Some of this is developmentally programmed, such as the inhibition of apoptosis by 
Polycomb group genes45.  However, it could be argued that cancer cells acquire their 
unique properties by micro-evolution into a specialized developmental program.  These 
characteristics allow neuroblasts to maximize their potential in their role, which is to 
generate a very large and complex organ in a short amount of time.  Yet, neuroblasts are 
still susceptible to cell death of some sort provided enough damage has occurred.  Even 
in the brat tumorigenic background, Fzy function is still required to maintain neuroblast 
viability.  Thus, neuroblasts might provide a model system for examining pathways and 
strategies for killing cancers which have developed resistance to apoptosis or have 
bypassed cell cycle checkpoints.  
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Figure 3.1. Graphical representation of neuroblast necrosis. 
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Figure 3.2. Proposed mutations to disrupt Fzy maintenance of neuroblasts. 
Model of Fzy WD40 repeats is based on sequence similarity to fission yeast Slp1/Cdc2039.  
Regions containing (A) fzy5032 (pink) substitution and (B) fzyAC-10 (cyan) substitution are shown.  
Nearby residues with potential to form protein-protein interactions shown in grey.  Proposed 
substation mutations will change polar or hydrophilic side chains to nonpolar or hydrophobic side 
chains in an attempt to disrupt potential interactions. 
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Figure 3.3. fzy genetic dominant modifier screen. 
(A-C) Larval brains of fzy sensitized genetic background (A) without a modifier, and with 
heterozygous chromosomal deficiencies that dominantly (B) enhance or (C) suppress the 
sensitized background.  Arrows mark Dpn+ neuroblasts.  
(D) Quantification and comparison of fzy mutant backgrounds.  Two independent replicates of fzy 
sensitized (fzyEP/5032) background are shown (mean ± S.D.).    
(E) Quantification of fzy sensitized background control and several chromosomal deficiencies 
that consistently suppressed or enhanced the background.  Brackets indicated deficiencies which 
overlap.  Red dotted lines encompass 95% confidence interval of control quantification (mean ± 
S.D.) 
(F) Map of genomic locus deleted in modifier deficiency 7660, an enhancer 57. 
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APPENDIX 1 
FZY POINT MUTATIONS CLONING PRIMERS 
 
 
 
 
D-box mutations: 
 
Val226Met 
For: GACAATATAGTGGCTATGGCCTTGGGCAGTT 
Rev: AACTGCCCAAGGCCATAGCCACTATATTGTC 
 
Ala384Phe 
For: ACGACCATCAAGCTTTTGTGCGTGCCTTGGC 
Rev: GCCAAGGCACGCACAAAAGCTTGATGGTCGT  
 
KEN-box mutation: 
 
Asn354Ala / Asn356Ala / Gln428Ala / Arg472Leu 
(used 3 pairs of stitching primers) 
For1: GCTAGCGGAGGCGCCGACGCTCTGGTGAATGTT 
Rev1: AACATTCACCAGAGCGTCGGCGCCTCCGCTAGC 
For2: TGGACTCCAAGTCGGCGGTCTGTTCTCTGC 
Rev2: GCAGAGAACAGACCGCCGACTTGGAGTCCA 
For3: CTGGACACACGTCACTAGTTCTCCAGATGGC 
Rev3: GCCATCTGGAGAACTAGTGACGTGTGTCCAG 
 
Fzy5032 adjacent mutations: 
 
Thr272Val 
For1: CCATCGGCAACAGCGTCGGTGCCGTGGAGC 
Rev1: GCTCCACGGCACCGACGCTGTTGCCGATGG 
 
Met289 (to Leu, codon CTG) 
For2: AGCGTCTGCGAGTGCTGGATGGACACAGTG 
Rev2: CACTGTGTCCATCCAGCACTCGCAGACGCT 
 
Ser293Ala 
For3: TGATGGATGGACACGCTGCCCGAGTGGGAT 
Rev3: ATCCCACTCGGGCAGCGTGTCCATCCATCA 
 
89 
 
His325 Val 
For4: TGCGTGCACGTGAGGTCAAGCTTTCCACAT 
Rev4: ATGTGGAAAGCTTGACCTCACGTGCACGCA 
 
Lys326 Leu 
For5: GTGCACGTGAGCACCTGCTTTCCACATTGT 
Rev5: ACAATGTGGAAAGCAGGTGCTCACGTGCAC 
 
FzyAC-10 adjacent mutations: 
 
Cys430Ala 
For1: CCAAGTCGCAGGTCGCTTCTCTGCTCTTTT 
Rev1: AAAAGAGCAGAGAAGCGACCTGCGACTTGG 
 
Ser431Ala 
For2: AGTCGCAGGTCTGTGCTCTGCTCTTTTCTC 
Rev2: GAGAAAAGAGCAGAGCACAGACCTGCGACT 
 
Met476 Leu 
For3: TCACGAGTTCTCCAGCTGGCCATGTCTCCGG 
Rev3: CCGGAGACATGGCCAGCTGGAGAACTCGTGA 
 
Each primer pair is complementary and used in combination with fzy 5’ and 3’ primers to 
generate fzy transgene fragments containing new point mutations. 
 
Highlighted bases represent mutations sites. 
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APPENDIX 2 
FZY DOMINANT MODIFIER SCREEN RESULTS 
 
 
Genetic background: fzy5032/fzyEP1028 
 
Initial screening candidates: Bloomington Stock Center third chromosome deficiencies 
 
Suppressor locus 1: 
Overlap of Df(9086) and Df(24990) 
Includes genes: CG18616, CG18530, CG11598, CG11600, CG11608, CG6753, 
CG6234, CG6225, CG14395, CG6188, CG43630, mbo, Cyp313a4, kar, Su(fu), 
Arp1, CG31347, CG14391, NijC, Past1, CG12279 , mus308, Men 
 
Suppressor locus 2: 
Overlap of Df(669) and Df(8925) 
Includes genes: CG2014, CR43613, Dr, CG7567, CG11470, CG31041, alph, 
CG7568, Diedel2, CG1907 
 
Enhancer locus: 
Overlap of Df(7660) and Df(26840) 
Includes genes: Mekk1, CG7718, gwl, CG14299, CG7720, CG18208, CG31226, 
CG14298, CG14297, Rh2, CG14294, CG34284, CG14292, endoA, CG14291, 
Xrp1 
